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ABSTRACT 
Evaluation of Various Dietary Supplements and Strategies to Enhance Growth 
and Disease Management of Hybrid Striped Bass Morone chrysops × M. saxatilis. 
(December 2005) 
Peng Li, B. A., Ocean University of China 
Chair of Advisory Committee: Dr. Delbert M. Gatlin, III 
 
The US hybrid striped bass (Morone chrysops × M. saxatilis) industry has been 
negatively impacted by infectious diseases because there are very few approved drugs 
and vaccines. Therefore, a series of experiments was conducted to explore the potential 
use of various dietary supplements including autolyzed brewers yeast, the commercial 
prebiotic GroBiotic®-A, oligonucleotides and levamisole for improvement of hybrid 
striped bass growth, immunity and resistance to disease caused by various pathogenic 
bacteria.  
In two trials with brewers yeast, fish fed diets supplemented with yeast at 2% 
generally showed enhanced weight gain and feed efficiency compared with those fed a 
basal diet. Brewers yeast also positively influenced resistance to S. iniae infection. In 
addition, results of immune response assays demonstrated that brewers yeast can be 
administered for relatively long periods without causing immunosuppression.  
GroBiotic®-A (Grobiotic™ AE) also resulted in significantly enhanced weight 
gain, innate immune responses and resistance of juvenile hybrid striped bass to S. iniae 
infection. An additional experiment with sub-adult fish showed significantly reduced 
mortality of fish fed a diet supplemented with GroBiotic®-A at 2% when subjected to an 
 iv
in-situ Mycobacterium marinum challenge. This is the first report of positive effects from 
dietary prebiotics for fish health management, although many fundamental questions 
should be pursued further. 
Dietary supplementation of a commercial oligonucleotide product (Ascogen P®) 
at 0.5% of the diet was shown to enhance resistance of hybrid striped bass against S. iniae 
infection and increased their neutrophil oxidative radical production. However, the effect 
on growth was marginal. 
Dietary levamisole supplementation at a low level (100 mg/kg) enhanced the 
growth and feed efficiency of juvenile hybrid striped bass. However, an elevated dosage 
(1000 mg/kg diet) strongly suppressed growth, feed intake and feed efficiency.  
Hypothesized beneficial influences, including antibody production and resistance to S. 
iniae and A. hydrophila were not substantiated. Although dietary levamisole increased 
fish macrophage respiratory burst, an in vitro study failed to show a direct effect on 
cultured macrophages.    
This suite of studies demonstrated the potential use of some dietary supplements 
to enhance hybrid striped bass production. Thus, immunonutrition represents a valuable 
strategy to apply in aquaculture.  
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CHAPTER I 
 
INTRODUCTION 
 
Aquaculture has grown at an average rate of 8.9 percent per year since 1970 and 
has become the fastest growing sector of food production in the world (FAO, 2004; 
Subasinghe, 2005). In 2002, total world aquaculture production was reported to be 51.4 
million tons by quantity and $60 billion by value (FAO, 2004).  It was estimated that the 
aquatic products generated from aquaculture by 2050 will be between 177.9 (assuming 
growing fisheries at 0.7% per year) and 209.5 (assuming stagnating fisheries) million 
tons per year (Wijkström, 2003). Despite the encouraging trends, several constraints may 
have negative impact on the growth of aquaculture. Diseases are one of these primary 
limiting factors (FAO, 2004). Although global economic losses from aquaculture diseases 
have not been compiled, disease reports from many regions of the world have been 
increasing with advances in the live aquatic animal trade (reviewed by Subasinghe, 2005).  
Current methods for prevention and treatment of infectious aquatic diseases 
include a limited number of government-approved antibiotics and chemotherapeutics and 
limited vaccines that can be used to compliment environmental management. However, 
use of antibiotics has been seriously criticized for development of antibiotic-resistant 
bacterial strains (FAO, 2002), potential impact on the non-target bacterial communities in 
the environment (Stickney, 1997) and risk of antibiotic residues in aquaculture products 
that are harmful to antibiotic-intolerant human consumers (FAO, 2002). In addition,  
 
This dissertation follows the style of Aquaculture. 
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numerous studies have shown that most antibiotics including FDA-approved 
oxytetracycline can suppress the natural immunity of fish, increasing the risk of infection 
from non-bacterial pathogens such as viruses, fungi and parasites (Rijkers et al., 1980, 
1981; Siwicki et al., 1989; Taffaella et al., 1999, Luden et al., 1999, 2002). Because 
vaccines are usually delivered via injection instead of dietary supplementation or 
immersion, tremendous amounts of human labor are required to deliver the vaccines and 
there is associated handling stress on the fish that may offset the efficacy of the vaccines 
to a great extent. While considerable effort in vaccine development has continued, 
vaccines against some severe infectious diseases are still unavailable.  
 
1. Fish Immune System 
Traditionally, the immune system of fish is divided into two primary components, 
innate and adaptive. The innate immune system consists of physical barriers including 
scales, mucus, gills and epidermis; immunocytes including phagocytic cells, non-specific 
cytotoxic cells, endothelial cells and a wide variety of humoral components such as 
transferrin, lysozyme, complement, protease inhibitors, natural antibodies, lectins, 
pentraxins, cytokines, chemokines and antimicrobial peptides from internal secretion of 
various tissues and cell types (reviewed by Magnadóttir, 2005). The adaptive immune 
responses are dependent on the activities of B lymphocytes and T lymphocytes, which 
function in specific immunoglobulin production and cytotoxic activities and 
immunomodulation via cytokines (Shoemaker et al., 2001).  
Increasing evidence on the essential interaction between innate and adaptive 
immune systems has emerged in recent years. Innate immunity has been demonstrated to 
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be essential in activation of acquired immunity (Fearon and Locksley, 1996; Fearon, 
1997). The activation of innate recognition components, through the stimulation of 
phagocytes, produces cytokines and chemokines that activate the complement system and 
various cell receptors and stimulating T-, B- and antigen- presenting cells (reviewed by 
Lo et al., 1999), which have been tentatively confirmed in fish (Dixon and Stet, 2001). A 
recent study (Acosta et al. 2005) showed that vaccination could enhance the inducible 
nitric oxide responses of macrophages from gilthead seabream, suggesting an important 
role of immunological memory in innate immune response.  
Considerable progress has been made in molecular immunology of aquatic 
animals and many immune genes including cytokines, receptors and humoral proteins 
have been sequenced. Although the homology of these proteins among various species 
may be low and restrict the application of molecular tools across species (Secombes, 
2002), it is becoming increasingly feasible to evaluate environmental factors, especially 
dietary components, via quantitatively measuring expression of genes associated with 
growth, metabolism and health, at least for some model fishes such as rainbow trout, 
gilthead seabream and channel catfish.      
 
2. Overview of Dietary Strategies for Fish Health Management 
Prepared diets not only provide the essential nutrients that are required for normal 
physiological functioning but also may serve as a medium by which fish receive certain 
compounds that may alter endocrine activity, immunity and other physiological responses 
(Gatlin, 2002; Li et al., 2005). The research pertaining to dietary modulation of immunity 
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and disease resistance has been conducted for over 15 years and encouraging progress 
has been made. Major dietary strategies are summarized as follows: 
1. Fortification with immunonutrients. It is known that some nutrients have specific 
functions in immune responses, such as arginine as the substrate of nitric oxide 
production (reviewed by Wu and Morris, 1998), glutamine for energy (Wu et al., 1991), 
nucleotides for cell proliferation and immungene expression (reviewed by Li and Gatlin, 
2005), as well as vitamins C and E for protecting phagocytes from oxidative stress and 
destruction (Bendich, 1990). Elevated supplementation of vitamin C has been shown to 
enhance immune responses and disease resistance in various fish species (Ai et al., 
2004; Lin and Shiau, 2005).    
2. Supplementation of immunostimulants and metabolism-modifying chemicals. There 
has been heightened attention in recent years to the use of natural microbial products in 
aquafeeds which may enhance the immune responses and disease resistance of 
aquacultured fishes by altering the signaling of immunocytes (reviewed by Sakai, 1999; 
Gatlin, 2002). The most extensively studied immunostimulant is β-glucans, constituents 
of yeast cell walls. Studies with various products such as peptidoglycan, 
lipopolysaccharide, bacterial fermentation products (FK-650) and herbal extracts also 
have shown promise as dietary supplements for disease management in aquaculture. 
Many synthetic drugs also have been used in terrestrial animal production for 
modification of the somatogenic axis toward rapid growth and enhanced feed efficiency. 
Up-regulation of the immune system by anabolic hormones such as growth hormone 
(GH) and insulin-like growth factor (IGF-1) has been confirmed in fishes (Harris and 
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Bird, 2000). Therefore such drugs may be important for development of new dietary 
strategies in aquaculture, although current research seems limited to levamisole.  
3. Supplementation of gut microflora-altering components. Diet supplementation with 
live microorganisms such as bacteria or yeast to alter composition of the 
gastrointestinal tract of fish has been shown to enhance growth as well as reduce 
disease risk of various species (reviewed by Gatescoupe, 1999; Irianto and Austin, 
2002). The evidence of beneficial effects of probiotics gave rise to the concept of 
prebiotics, which are defined as non-digestible feed ingredients which beneficially 
affect the host by selectively stimulating growth and activating health-promoting 
bacteria in the intestinal tract. However, potential use of prebiotics in aquaculture has 
not been pursued.  
4.  Passive immunization using pathogen-specific antibody supplementation to the diet. 
Pathogenic bacteria-specific Ig Y can be isolated from egg yolk produced by laying 
hens vaccinated with killed fish pathogenic bacteria. The antibody could be transferred 
to fish by oral administration, indicating a novel method in prevention of certain 
diseases. Successful reports on anti-Vibrio and anti-Yersinia Ig Y in rainbow trout (Lee 
et al., 2000; Arasteh et al., 2004) as well as anti-Edwardsiella Ig Y in Japanese eel 
(Gutierrez et al, 1993) have shown promise of passive immunity as a dietary 
supplementation strategy for enhancement of fish health.  
 
3. Hybrid striped bass 
Hybrid striped bass culture began in the late 1980s and has rapidly developed into 
a major aquaculture industry in the US. The production in the US was 5.2 million 
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kilograms in 2003 and was projected to be 6.4 million kilograms in 2004 (Calberg, 
personal communication). Although a wide range of pathogenic organisms has been 
documented (Plumb, 1997), several bacteria such as Streptococcus iniae, Aeromonas 
hydrophila and Mycobacterium marinum are posing major threats to this industry in the 
US.  The economic loss from S. iniae infection alone was estimated as $2 million 
annually (Ostland, 2003). Because there is no therapeutic agent approved by the US Food 
and Drug Administration or any commercial vaccines specifically for hybrid striped bass, 
research on dietary modulation of immunity and disease resistance is of special relevance.   
Sealey and Gatlin (2002a, b) demonstrated that dietary anti-oxidative vitamins (ascorbic 
acid and α-tocopherol) in vivo and in vitro modulated respiratory burst of hybrid striped 
bass macrophages; however, this beneficial influence did not lead to enhanced resistance 
against S. iniae (Sealey and Gatlin, 2002c). Therefore, further research on dietary 
supplementation strategies in hybrid striped bass is needed, not only to provide insights 
concerning interactions between nutrition and physiological responses but also to provide 
practical solutions to reduce basic risk from infectious diseases for the hybrid striped bass 
industry.  
The objectives of the proposed research were:  
1. To evaluate autolyzed brewers yeast, a commercial prebiotic, nucleotides and 
levamisole as individual dietary supplements for growth and disease management 
of hybrid striped bass.  
2. To explore potential influences of dosage and long-term administration of these 
supplements.  
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3. To examine the in vitro effects of some soluble supplements such as levamisole 
on hybrid striped bass macrophage function.       
 8
CHAPTER II 
 
EVALUATION OF BREWERS YEAST (Saccharomyces cerevisiae) AS A FEED 
SUPPLEMENT FOR HYBRID STRIPED BASS (Morone chrysops × M. saxatilis)* 
 
1. Introduction 
Hybrid striped bass production is considered to be the fastest growing segment of 
the U.S. aquaculture industry over the past decade and is poised to become a global 
seafood delicacy in the 21st century (Harrell and Webster, 1997; Kohler, 2000). 
However, one major constraint to hybrid striped bass aquaculture is suboptimal 
production efficiency stemming from intrinsically high sensitivity to various stressors and 
susceptibility to infectious agents during normal aquacultural production. Although viral 
diseases are not a primary threat to fish culture activity thus far, heavy economic loss 
may be caused by other pathogenic organisms, including bacteria, fungus and protozoan 
ectoparasites (Kohler, 2000).  
In recent years, there have been growing concerns about the adverse effects of the 
bacterium Streptococcus iniae in the aquaculture of many economically important marine 
and freshwater fish species including rainbow trout (Eldar and Ghittino, 1999), Nile 
tilapia (Bowser et al., 1998), hybrid tilapia (Perera et al., 1997), yellowtail (Kaige et al., 
1984), Japanese flounder (Nguyen et al., 2001a, b), hybrid striped bass (Sealey and 
Gatlin, 2002a), red drum (Eldar et al., 1999; Colorni et al., 2002), rabbitfish Siganus  
 
 
* Reprinted from Aquaculture, Vol 219, Li, P., Gatlin, D. M. III, Evaluation of brewers yeast 
(Saccharomyces cerevisiae) for a feed supplement for hybrid striped bass (Morone chrysops × 
M. saxatilis), pp. 681-692, Copyright 2003, with permission from Elsevier Science.   
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(Yuasa et al., 1999) and even wild fishes (Colorni et al., 2002). This bacterium may cause 
heavy losses from mortality, reduced growth and unmarketable appearance in various fish 
species. Unfortunately, hybrid striped bass is one of the most susceptible fish to S. iniae 
infection. S. iniae is also associated with acute cellulitis in humans. Although some 
reports suggest that the fish and human S. iniae might be genetically different (Dodson et 
al., 1999), all reported occurrences of the human disease were associated with puncture 
wounds or abrasions and handling of infected fish or contaminated water (Greenlees et 
al., 1998). Therefore, an effective preventive strategy is not only needed to limit 
economical loss in aquaculture, but also to protect the health of aquaculturists and fish 
processing workers.  
In aquaculture, traditional methods for treating infective pathogens include a 
limited number of government-approved antibiotics and chemotherapeutics. However, 
the disadvantages such as marginal effectiveness and high cost are obvious (Sealey and 
Gatlin, 2001). These treatments also may cause the accumulation of chemicals in the 
environment and/or fish, thus posing potential threats to consumers and the environment. 
An alternative strategy, besides vaccine development, is nutritional modulation of 
immune responses and disease resistance of aquaculture species. Research on the subject 
of nutritional modulation, especially evaluation of natural extracts or synthetic 
compounds, which may enhance the immune responses and disease resistance of hybrid 
striped bass, is still in its infancy. In the United States, because there is no therapeutic 
approved by the U.S. Food and Drug Administration specifically for hybrid striped bass, 
research on this topic is of special urgency.  
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Yeast by-products from the brewing industry are natural diet additives that have 
been shown to positively influence non-specific immune responses (Siwicki et al., 1994 
and Anderson et al., 1995) as well as growth (Rumsey et al., 1991; Oliva-Teles and 
Goncalves, 2001) of some fish species. However, yeast products have not been 
investigated with hybrid striped bass. In addition, doses and time of administration have 
been recognized to have important effects on immunostimulant function, and efficacy of 
oral administration of immunostimulants has been reported to decrease over time (Sakai, 
1999). The present study was conducted to determine the effects of graded levels of 
brewers yeast Saccharomyces cerevisiae on growth performance, body composition and 
resistance to S. iniae infection in hybrid striped bass. In addition, the efficacy of long-
term oral administration of brewers yeast was explored by comparing various immune 
responses.  
 
2. Materials and Methods 
2.1. Experiment 1 
An initial feeding trial was conducted to evaluate growth performance of hybrid 
striped bass fed graded levels of brewers yeast. The basal diet of Keembiyehetty and 
Gatlin (1997), which utilized menhaden meal as the protein source, was modified to 
contain 40% protein, 10% lipid and an estimated digestible energy level of 3.5 kcal/kg 
(Table 1). This diet satisfied and/or exceeded all known nutrient requirements of hybrid 
striped bass (Gatlin, 1997) or other warmwater fishes (National Research Council, 1993). 
Dried brewers yeast (Brewtech®) was supplied by International Ingredient Corporation  
(St. Louis, MO, USA). Three incremental levels (1%, 2% and 4% of diet) were added to  
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Table 1. Composition of experimental diets in experiment 1 
Constituent Basal Diet Yeast Supplementation (%) 
  1 2 4 
Ingredient (% dry weight) 
Menhanden fish meala 59.0 59.0 59.0 59.0 
Dextrinb 22.5 22.5 22.5 22.5 
Menhaden oila 3.7 3.7 3.7 3.7 
Mineral premixc 3.0 3.0 3.0 3.0 
Vitamin premixc 4.0 4.0 4.0 4.0 
Carboxymethyl celluloseb 2.0 2.0 2.0 2.0 
Celluloseb 5.8 4.8 3.8 1.8 
Brewers yeastd 0 1 2 4 
Proximate analysis (% dry matter) 
Dry matter 88.5 92.6 92.4 92.5 
Crude protein (N×6.25) 39.8 40.8 40.7 42.1 
Crude lipid 11.2 10.4 10.8 10.4 
Ash 14.2 14.0 14.5 14.4 
a Omega Protein Corporation, Reedville, VA. Menhaden fish meal contained 67.8% 
protein and 10.7% lipid at a dry-weight basis. 
b US Biochemical Corp., Cleveland, OH. 
c Same as Gaylord and Gatlin (2000) 
d International Ingredient Corporation, St. Louis, MO. Brewers yeast contained 50.7% 
crude protein and 2% crude lipid (dry weight basis). 
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the control diet in place of cellulose. Procedures for diet preparation and storage were as 
previous described (Rawles and Gatlin, 1998).  
Juvenile hybrid striped bass (Morone saxatilis×M. chrysops) were obtained from 
a commercial supplier (Keo Fish Farm, Keo, AR) and maintained indoors at the Texas 
A&M University Aquacultural Research and Teaching Facility prior to the feeding trial. 
Fish were then graded by size and groups of 10 fish with a total weight of 253±5 g/group 
were stocked into 110-l aquaria. The basal diet was fed to all fish in 110-l aquaria during 
a 1-week conditioning period. Water flow rate were maintained at approximately 650 
ml/min via a recirculating system, which maintained water quality through mechanical 
and biological filtration (Sealey and Gatlin, 2002b). Salinity was maintained at 2.5–3.5‰ 
using well water and synthetic sea salt (Fritz Industries, Dallas, TX, USA). Low-pressure 
electrical blowers provided aeration via air stones and maintained dissolved oxygen (DO) 
levels at or near saturation. Water temperature was at 26±1 °C throughout the trial and a 
12-h light:12-h dark photoperiod was maintained with fluorescent lights controlled by 
timers.  
Each diet was fed to fish in triplicate groups at 3% of body weight daily, except 
during the last week of the trial, in which feeding rate reduced to 2.5% of body weight. 
The feeding trial was conducted for 6 weeks. Group weights of fish in each aquarium 
were obtained weekly and feed amounts adjusted accordingly. At the end of both feeding 
trials, three representative fish from each aquarium were anesthetized with tricaine 
methane sulfonate (MS-222), and approximately 0.5 ml of blood was collected from the 
caudal vasculature using a 1-ml syringe and 27-gauge needle for hematocrit 
determination. 
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2.2. Experiment 2 
The second feeding trial was conducted to further evaluate growth responses of 
hybrid striped bass fed graded levels of brewers yeast as well as some of their immune 
responses. The basal diet formulation was the same as one in Experiment 1. Three 
incremental levels of dried brewers yeast (1%, 2% and 4% of diet) were added to the 
basal diet and cellulose, menhaden meal and menhaden oil were adjusted to provide 
isonitrogenous and isolipidic diets (Table 2).  
Prior to initiation of this feeding trial, juvenile hybrid striped bass obtained from 
Keo Fish Farm were subjected to a 2-week conditioning period to adjust to standardized 
regimes in a recirculating culture system consisting of 38-l aquaria (Gaylord and Gatlin, 
2000). Water was maintained in the system at 25±1 °C and was provided to each 
aquarium at a rate of 500 ml/min. Salinity was maintained to 1.5–2‰. Optimal water 
quality (DO≥6 mg/l, total ammonia nitrogen ≤0.3 mg/l) was maintained by biofiltration 
and aeration as in Experiment 1. Groups of 15 juvenile hybrid striped bass weighing 
approximately 9.7 g/fish were stocked into individual aquaria such that initial weight 
averaged 142±5 g/group. Each experimental diet was fed to four replicate groups of fish 
for 8 weeks. All groups were fed their respective diets at the same fixed rate (initially 5% 
of body weight per day and gradually reduced to 3%). This rate was adjusted each week 
to maintain a level approaching apparent satiation. Fish were fed in the morning and 
evening, 7 days each week. Growth and feed efficiency were monitored weekly by 
collectively weighing each group of fish.  
At the end of this feeding trial, three representative fish from each aquarium were 
anesthetized with MS-222, and blood collected as previously described for Experiment 1.  
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Table 2. Composition of experimental diets in experiment 2 
Constituent Basal Diet Yeast Supplementation (%) 
  1 2 4 
Ingredient (% dry weight) 
Menhanden fish meala 57.9 57.2 56.4 55.0 
Dextrinb 24.9 25.1 25.0 24.9 
Menhaden oila 2.4 2.4 2.5 2.7 
Mineral premixc 3.0 3.0 3.0 3.0 
Vitamin premixc 4.0 4.0 4.0 4.0 
Carboxymethyl celluloseb 2.0 2.0 2.0 2.0 
Celluloseb 5.8 5.3 5.1 4.4 
Brewers yeastd 0 1.0 2.0 4.0 
Proximate analysis (% dry matter) 
Dry matter 89.6 88.5 88.6 88.8 
Crude protein (N×6.25) 40.4 40.5 40.7 40.7 
Crude lipids 9.6 9.0 9.5 9.2 
Ash 14.2 14.4 14.4 14.2 
a Omega Protein Corporation, Reedville, VA. Menhaden fish meal contained 69% protein and 
13.2% lipid at a dry-weight basis. 
b US Biochemical Corp., Cleveland, OH. 
c Same as Gaylord and Gatlin (2000) 
d International Ingredient Corporation, St. Louis, MO. Brewers yeast contained 50.7% crude 
protein and 2% crude lipid (dry weight basis). 
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After a sample of whole blood was taken for hematocrit determination, serum was 
isolated by centrifugation (3000×g for 5 min) and kept at −80 °C for lysozyme assay 
(Engstad et al., 1992). After bleeding, the fish were frozen for whole body composition 
analysis (Rawles and Gatlin, 1998).  
An additional 30 fish previously fed each of the experimental diets for a total of 9 
weeks were exposed to an estimated LD50 dose of S. iniae. A virulent isolate of S. iniae 
originally obtained from the brain of an infected tilapia (Oreochromis sp.) was 
biochemically identified and provided by the Texas Veterinary Medicine Diagnostic 
Laboratory. The bacterial suspension was prepared according to the method described by 
Sealey and Gatlin (2002b) and diluted to a concentration of 2.6×105 CFU/ml in fresh well 
water. Thirty fish from each dietary treatment, pooled separately in mesh baskets, were 
immersed in the bacterial suspension for 2 h. After bacterial exposure, the 30 fish from 
each dietary treatment were divided into three groups of 10 and placed into 38-l aquaria 
in an isolated culture system that received a constant supply of well water at 25±1 °C. 
Fish continued to be fed their respective diets to apparent satiation twice daily and 
mortality was monitored for 2 weeks. The brains of dead fish were streaked on modified 
selective agar (Nguyen and Kanai, 1999) to confirm death from S. iniae.  
After the second feeding trial and diseases challenge, additional fish continued to 
be fed each experimental diet to apparent satiation for a total of 16 weeks. After this 
extended feeding trial period, four fish from each treatment were bled from the caudal 
vasculature. Neutrophil oxidative radical production was determined following the 
procedure described by Siwicki et al. (1994). Absorbance was converted to Nitro Blue 
Tetrazolium (NBT) units based on a standard curve of NBT diformazan per milliliter of 
 16
blood. Serum samples were separated as described above for lysozyme assay (Engstad et 
al., 1992). Also, after 16 weeks, eight fish per treatment were euthenized and head kidney 
samples were taken for macrophage isolation and assay of extracellular and intracellular 
superoxide anion. This assay followed the procedure of Sealey and Gatlin (2002a). The 
amount of extracellular superoxide anion was calculated from the formula: nmol 
superoxide anion/well=(∆absorbance after 60 min×100)/6.3 (Pick and Mizel, 1981).  
Data from both feeding trials and the bacterial challenge were subjected to 
analysis of variance and Duncan's multiple range test using the Statistical Analysis 
System (SAS, 1985). Differences in treatment means were considered significant at 
P<0.05.  
 
3. Results 
3.1. Experiment 1 
In Experiment 1, hybrid striped bass fed the diets supplemented with 1% and 2% 
Brewtech dried brewers yeast had up to 20% more weight gain compared to fish fed the 
basal diet during the course of the feeding trial (Table 3). However, fish fed the diet 
supplemented with 4% brewers yeast had weight gain similar to fish fed the basal diet 
and responses of fish fed the various diets were not significantly different. One replicate 
group of fish fed the control diet also was excluded from analysis because of mortality 
experienced during weighing due to toxicity from net disinfectant. Survival and 
hematocrits of fish in all other replicates were high and not affected by diet (Table 3).  
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3.2. Experiment 2 
In Experiment 2, weight gain, feed efficiency and survival of fish fed all 
experimental diets were excellent (Table 4). In this experiment, however, dietary effects 
on weight gain tended to be significant at P<0.1, and fish fed the diets with 1% and 4% 
brewers yeast had the highest gain. Hematocrits of fish fed the various diets were not 
significantly affected by diet. Serum lysozyme was highly variable in hybrid striped bass 
in Experiment 2 (Table 4), with no significant effects of dietary yeast supplementation 
observed. Whole body composition of hybrid striped bass was not significantly affected 
by the dietary supplementation of brewers yeast in Experiment 2 (Table 5).  
 
3.3. S. iniae challenge 
The controlled exposure of hybrid striped bass to a virulent strain of S. iniae at the 
end of the feeding trial in Experiment 2 resulted in limited mortality after the challenge 
(Fig. 1). Fish fed diets with 2% and 4% Brewtech brewers yeast did not experience 
mortality, while 20% and 10% mortality was observed in fish fed the control diet and 1% 
brewers yeast supplemented diet, respectively, although differences in survival were not 
statistically significant.  
 
3.4. Immune responses after long-term administration 
After 16 weeks of feeding the diet in Experiment 2, neutrophil oxidative radical 
production, serum lysozyme, intracellular and extracellular superoxide anion of head 
kidney phagocytic cells were tested (Table 6). Significant differences (P<0.01) in  
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Fig. 1.  Percent cumulative survival rate of hybrid striped bass fed incremental levels of 
brewers yeast (1, 2 and 4%) for 9 weeks and subsequently exposed to S. iniae bath (P = 
0.1). Symbols represent means of three replicate tanks per treatment. Pooled SE was 5.77.  
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neutrophil oxidative and extracellular superoxide anion of head kidney phagocytic cells 
were observed among fish fed control diet and yeast-supplemented diets.  
 
4. Discussion 
Single cell proteins, including yeast and bacteria, have been viewed as promising 
substitutes for fishmeal in fish diets. Researchers have evaluated the nutritional value of 
brewers yeast S. cerevisiae in lake trout (Rumsey et al., 1990), rainbow trout (Rumsey et 
al., 1991) and sea bass (Oliva-Teles and Goncalves, 2001) by comparing growth 
performance, feed efficiency, liver uricase and nitrogen retention. Based on these studies, 
brewers yeast could replace up to 25–50% of fish meal protein without adversely 
affecting growth of these species. In the present study, brewers yeast was evaluated for its 
potential as an immunostimulant at relatively low inclusion levels.  
In Experiment 1, the fish were not in optimal condition as reflected in chronic, 
low-level mortality (as high as 15%). Dietary supplementation of brewers yeast, 
especially at 1%, tended to improve the growth and health of fish in that experiment. In 
Experiment 2, weight gain, feed efficiency and survival of fish fed all diets were 
excellent. The fishes' high state of health and optimal environmental conditions may have 
limited potential expression of dietary effects on fish performance.  
Hemocrits of fish fed the various diets in Experiments 1 and 2 were variable, but 
within normal ranges (Hrubec et al., 2001; Sealey and Gatlin, 2002c) and highest for fish 
fed 1% brewers yeast. Differences in fish size may have accounted for some of the 
differences in hematocrit values observed between experiments. Serum lysozyme, which 
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is one measure of non-specific immunity, was highly variable in hybrid striped bass in 
both experiments. The average lysozyme levels in the present study were within the range 
reported by Sealey and Gatlin (2002c).  
Although Streptococcicosis is attracting more attention, information on effect of 
nutrition on resistance to this disease is limited. Matsuyama et al. (1992) observed 
intraperitoneal injection of β-1,3-glucan derived from Schizophyllum commune and 
Sclerotium glucanicum could significantly enhance the percent survival of yellowtail 
after Streptococcus sp. challenge. However, for the present, few strategies other than 
vaccination have been proven to enhance resistance to S. iniae infection of any fish 
species. There is some evidence that antibiotic treatment has been ineffective (Klesius et 
al., 2000). After exposure to S. iniae in Experiment 2, hybrid striped bass fed diets with 
2% and 4% brewers yeast did not experience mortality, while 20% mortality was 
observed in fish fed the control diet. Constant disease signs were observed including 
dermal hemorrhages around the mouth, base of fins and anus, erratic swimming, dark 
skin pigmentation and slow acceptance or refusal of feed, which are similar to those of 
tilapia described by Perera et al., 1994 and Perera et al., 1997 and Evans et al. (2000). 
However, noticeable better feeding and less dark skin pigmentation were generally 
observed in fish fed diets with 2% and 4% yeast supplementation.  
Some reports (Matsuo and Miyazano, 1993; Sakai, 1999) have indicated that 
long-term oral administration of immunostimulants to fish may induce 
immunosuppression. To determine this phenomenon in hybrid striped bass, after 16 
weeks of feeding, non-specific immune responses including blood neutrophil oxidative 
radical production, serum lysozyme, extracelluar and intracellular superoxide anion of 
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head kidney macrophages were tested. Significant differences (P<0.01) in blood 
neutrophil oxidative radical production and extracellular superoxide anion of head kidney 
phagocytic cells were observed among fish fed the basal diet and yeast-supplemented 
diets. These results confirm early reports (Siwicki et al., 1994; Anderson et al., 1995) on 
effects of dietary brewers yeast on immune responses including neutrophil oxidative 
radical production and serum immunoglobulin level in rainbow trout. No significant 
differences of serum lysozyme and intracellular superoxide anion of phagocytic cells 
were observed among fish. The intracellular superoxide anion and extracellular 
superoxide anion of head kidney phagocytic cells of fish fed the basal diet were observed 
to be similar to that of Sealey and Gatlin, 2002b and Sealey and Gatlin, 2002c.  
Brewers yeast is a source of nucleic acids and polysaccharides including glucans. 
β-1,3-glucans have been recognized to effectively enhance immune functions of many 
aquaculture species including African catfish (Yoshida et al., 1995), Atlantic salmon 
(Engstad et al., 1992), rainbow trout (Jorgensen et al., 1993; Siwicki et al., 1994) and 
shrimp Penaeus monodon (Thanardkit et al., 2002). β-1,3-Glucan is generally viewed as 
the factor in brewers yeast with a known immunological mechanism (Gannam and 
Schrock, 2001). Sakai et al. (2001) reported that the nucleotides from brewers yeast RNA 
were capable of enhancing the phagocytic and oxidative activities of kidney phagocytic 
cells, serum lysozyme in common carp as well as resistance to Aeromonas hydrophila. 
Burrells et al. (2001) also reported that dietary nucleotides, extracted from brewers yeast, 
could enhance resistance to various pathogenic infections in Atlantic salmon. However, 
the extent to which RNA in brewers yeast contributes to the beneficial influences of 
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dietary brewers yeast on immune responses and resistance to S. iniae infection of hybrid 
striped bass is not clear.  
It was concluded that brewers yeast positively influenced growth performance and 
feed efficiency of hybrid striped bass as well as resistance to S. iniae infection. In 
addition, results of immune response assays demonstrate that brewers yeast can be 
administered for relatively long periods without causing immunosuppression.  
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CHAPTER III 
 
DIETARY BREWERS YEAST AND THE PREBIOTIC GROBIOTIC™AE 
INFLUENCE GROWTH PERFORMANCE, IMMUNE RESPONSES AND 
RESISTANCE OF HYBRID STRIPED BASS (Morone chrysops×M. saxatilis) to 
Streptococcus iniae INFECTION*  
 
1. Introduction 
Hybrid striped bass production is considered to be the fastest growing segment of 
the U.S. aquaculture industry over the past decade and has spread to several countries and 
regions in Europe and Asia (Harrell and Webster, 1997; Hiney et al., 2002).  It is known 
that most of the common disease-causing organisms associated with various aquacultured 
fish also may affect cultured hybrid striped bass (Plumb, 1997). In recent years, 
Streptococcus iniae has become one of the most threatening pathogenic organisms in 
hybrid striped bass aquaculture and caused about $ 2 million of economic loss to USA 
hybrid striped bass producers in 2002 (Ostland, 2003). Although positive results have 
come from experimental treatment of this disease in tilapia with oxytetracycline (Darwish 
et al., 2002) and in hybrid striped bass with enrofloxacin (Stoffregen et al., 1996), these 
drugs are still under investigation and currently not approved by the U.S. Food and Drug 
Administration to treat bacterial diseases of hybrid striped bass. 
Proper nutrition has long been recognized as a critical factor in promoting normal  
 
* Reprinted from Aquaculture, Vol 231, Li, P., Gatlin, D. M. III, Dietary brewers yeast and the 
prebiotic Grobiotic™AE influence growth performance, immune responses and resistance 
of hybrid striped bass (Morone chrysops×M. saxatilis) to Streptococcus iniae infection, pp. 
445-456, Copyright 2004, with permission from Elsevier Science.   
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growth and sustaining health of fish. Prepared diets not only provide the essential 
nutrients that are required for normal physiological functioning but also may serve as the  
medium by which fish receive other components that may affect their health (Gatlin, 
2002). Although the concept of functional feeds is novel to the aquaculture industry, it 
represents an emerging new paradigm to develop diets that extend beyond satisfying 
basic nutritional requirements of the cultured organism. For hybrid striped bass, dietary 
requirements for the most essential nutrients have been established to provide balanced 
diets than satisfy metabolic needs (Gatlin, 1997; Webster, 2002); however, research on 
optimization of diets to enhance health is still in its infancy. Probiotics, live microbes that 
may serve as dietary supplements to improve the intestinal microbial balance have 
received some attention in aquaculture (Gatesoupe, 1999; Irianto and Austin, 2002). 
Evidence of the beneficial effects of probiotics gave birth to the concept of prebiotics 
(Gibson and Roberfroid, 1995; Teitelbaum and Walker, 2002), which are defined by 
Gibson and Roberfroid (1995) as “a nondigestible food ingredient which beneficially 
affects the host by selectively stimulating the growth of and/or activating the metabolism 
of one or a limited number of health-promoting bacteria in the intestinal tract, thus 
improving the host’s intestinal balance”.  Examples of prebiotics include mannan 
oligosaccharides (White et al., 2002), lactose (Szilagyi, 2002), as well as oligofructose 
and inulin (Teitelbaum and Walker, 2002). Information pertaining to prebiotics in 
aquaculture is extremely limited.  
Brewers yeast (Saccharomyces cerevisiae) is a natural product from the brewing 
industry that contains various immunostimulating compounds such as β-glucans, nucleic 
acids as well as mannan oligosaccharides, and has been used as a diet additive for various 
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animals. It has been observed to be capable of enhancing immune responses (Siwicki et 
al., 1994; Ortuño et al., 2002) as well as growth (Lara-Flores et al., 2002) of various fish 
species and thus may serve as an excellent health promoter for fish culture. Li and Gatlin 
(2003) established the beneficial effects of partially autolyzed brewers yeast on immune 
responses of hybrid striped bass and resistance to Streptococcus iniae infection. 
GrobioticTMAE is a commercial prebiotic mixture of partially autolyzed brewers yeast, 
dairy ingredient components and dried fermentation products. The present study was 
conducted to determine the effects of graded levels of the prebiotic, GrobioticTMAE, on 
hybrid striped bass growth performance, immune responses and resistance to 
Streptococcus iniae infection as compared with brewers yeast.  
 
2. Materials and Methods 
2.1 Experimental Diets 
The basal diet of Keembiyehetty and Gatlin (1997), which utilized menhaden fish 
meal as the protein source, was modified to contain 40% protein, 10% lipid and an 
estimated digestible energy level of 3.5 kcal/kg (Table 7).  This diet satisfied and/or 
exceeded all known nutrient requirements of hybrid striped bass (Gatlin, 1997; Webster, 
2002) or other warmwater fishes (National Research Council, 1993). Partially autolyzed 
brewers yeast (Brewtech®) and GrobioticTMAE, a mixture of partially autolyzed brewers 
yeast, dairy ingredient components and dried fermentation products, were supplied by 
International Ingredient Corporation (St. Louis, MO, USA). Two incremental levels (1 
and 2% of diet) of GrobioticTMAE and brewers yeast were added to the basal diet and 
cellulose, menhaden meal and menhaden oil were adjusted to provide isonitrogenous and  
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Table 7. Composition of experimental diets in feeding trials 1 and 2 
Constituent Basal diet 1% Brewers 
yeast 
2% Brewers 
yeast 
1% GrobioticTMAE 2% GrobioticTMAE 
Ingredient (% dry weight) 
Menhanden fish       
meal a 59.2 58.2 57.5 58.7 58.3 
Dextrin b 25.0 25.0 22.5 24.5 23.9 
Menhaden oil a 4.4 4.5 4.5 4.4 4.4 
Mineral premix c 4.0 4.0 4.0 4.0 4.0 
Vitamin premix c 3.0 3.0 3.0 3.0 3.0 
Carboxymethyl 
cellulose b 2.0 2.0 2.0 2.0 2.0 
Cellulose b 2.4 2.3 4.5 2.4 2.4 
Brewers yeast e 0 1.0 2.0 0 0 
GrobioticTMAE e 0 0 0 1.0 2.0 
Analyzed proximate composition (% dry matter) f 
Dry matter 92.1 92.7 92.6 92.1 90.4 
Crude protein 
(N×6.25) 
40.8 41.9 41.8 39.2 40.5 
Crude lipid 8.5 9.9 10.3 8.7 8.6 
Ash 14.5 14.4 15.6 14.4 13.9 
a Omega Protein Corporation, Reedville, VA. Menhaden fish meal contained 67.6% protein and 
9.5% lipid on a dry-weight basis. 
b US Biochemical Corp., Cleveland, OH. 
c Same as Gaylord and Gatlin (2000). 
d International Ingredient Corporation, St. Louis, MO. Contained 50.7% crude protein and 2% 
crude lipid (dry-weight basis). 
e International Ingredient Corporation, St. Louis, MO. Contained 30.0 % crude protein and 1.2 % 
crude lipid (dry-weight basis). 
f means of two analyses.  
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isolipidic diets (Table 7). 
 
2.2 Feeding trial 1 
Juvenile hybrid striped bass (Morone chrysops × M. saxatilis) were obtained from 
a commercial supplier (Keo Fish Farm, Keo, AR) and maintained indoors at the Texas 
A&M University Aquacultural Research and Teaching Facility prior to the feeding trial. 
Fish were then graded by size and groups of 13 fish with a total weight of 91.4 ± 4.3 g 
per group were stocked into 110-l aquaria. The basal diet was fed to all fish during a     2-
wk conditioning period. Water flow rate was maintained at approximately 650 ml/min via 
a recirculating system which maintained adequate water quality (total ammonia nitrogen 
≤ 0. 6 mg/l) through biological and mechanical filtration (Li and Gatlin, 2003). Salinity 
was maintained at 2.5-3.5 ‰ using well water and synthetic sea salt (Fritz Industries Inc., 
Dallas, TX). Low pressure electrical blowers provided aeration via air stones and 
maintained dissolved oxygen (DO) levels at or near saturation. Water temperature was 
controlled by ambient air and remained at 26 ± 1 oC throughout the trial. A 12 h light: 12h 
dark photoperiod was maintained with fluorescent lights controlled by timers. Each 
experimental diet was fed to five replicate groups of fish for 7 weeks.  All groups were 
fed their respective diets at the same fixed rate (initially 5% of body weight per day and 
gradually reduced to 3%).  This rate was adjusted each week to maintain a level 
approaching apparent satiation.  Fish were fed in the morning and evening, 7 days each 
week. Growth and feed efficiency were monitored weekly by collectively weighing each 
group of fish. 
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2.3 Feeding trial 2 
A second feeding trial was conducted to further evaluate immune responses and 
disease resistance of hybrid striped bass after feeding experimental diets for 4 weeks. 
Groups of 17 juvenile hybrid striped bass weighing approximately 19.7 g/fish were 
stocked into individual aquaria such that initial fish weight averaged 334 ± 3 g/group. 
These fish were raised in the same culture system as feeding trial 1. Each experimental 
diet was fed to three replicate groups of fish for 4 weeks.  All groups were fed their 
respective diets at the same fixed rate (initially 4% of body weight per day and gradually 
reduced to 3.5%). Growth and feed efficiency were monitored weekly by collectively 
weighing each group of fish. 
 
2.4 Sample collection and analysis 
At the end of the second feeding trial, two representative fish from each aquarium 
were anesthetized with tricaine methane sulfonate (MS-222), and approximately 0.5 ml 
of blood was collected from the caudal vasculature using a 1-ml syringe and 27-gauge 
needle. Whole blood neutrophil oxidative radical production was determined as described 
by Siwicki et al. (1994). Absorbance was converted to Nitro Blue Tetrazolium (NBT) 
units based on a standard curve of NBT diformazan/ml blood. Serum lysozyme activity 
was determined by turbidimetric assay as described by Jørgensen et al. (1993). A 
lysozyme activity unit was defined as the amount of enzyme producing a decrease in 
absorbance of 0.001 min-1. Three fish from each aquarium also were euthanized and head 
kidney samples were pooled for macrophage isolation and assay of extracellular and 
intracellular superoxide anion. This assay followed the procedure of Secombes (1990), as 
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modified by Sealey and Gatlin (2002a). The amount of extracellular superoxide anion 
was calculated from the formula of Pick and Mizel (1981). 
 
2.5 Bacterial challenge 
At the end of the second trial, an additional 30 fish previously fed each 
experimental diet were exposed to an estimated LD50 dose of Streptococcus iniae.  Before 
inoculation, this isolate of S. iniae was injected into hybrid striped bass to improve 
virulence, then reisolated by the Texas Veterinary Medical Diagnostic Laboratory. This 
isolate was grown in brain-heart infusion broth (EM Science, Darmstadt, Germany) in a 
shaking bath at 27 oC overnight as described by Sealey and Gatlin (2002b). The 
concentration of bacterial suspension was determined by the serial plate count method 
and diluted to 9.3 × 105 CFU/ml in fresh well water. Thirty fish from each treatment (10 
fish from each aquarium of each treatment), pooled separately in mesh baskets, were 
immersed in the bacterial suspension for 2 hours. After bath exposure, 30 fish from each 
dietary treatment were divided into three groups of 10, and placed into 38-l flow-through 
aquaria in an isolated culture system. Water temperature was maintained at 27 ± 1 oC 
with immersion heaters. Fish continued to be fed their respective diets to apparent 
satiation twice daily, and mortality was monitored for 19 days. The brains of both dead 
fish and surviving fish were streaked on modified selective agar to determine infection 
status and confirm death from S. iniae (Nguyen and Kanai, 1999).  
 
2.6 Statistics 
    Data from the feeding trials, immune response assays and the bacterial 
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challenge were subjected to analysis of variance and Duncan's multiple-range test using 
the Statistical Analysis System. Differences in treatment means were considered 
significant at P < 0.05. 
 
3. Results 
3.1 Feeding trial 1 
After the 7-week feeding period, enhanced weight gain was generally observed in 
fish fed diets supplemented with 1 and 2% GrobioticTMAE compared to those fed the 
basal diet, although only feed efficiency was significantly (P<0.05) improved (Table 8). 
Survival during feeding trial 1 was high and no significant differences were observed 
among treatments.  
 
3.2 Feeding trial 2  
No significant differences in growth, feed efficiency and survival were observed 
in fish fed experimental diets after 4 weeks. Neutrophil oxidative radical production of 
fish fed brewers yeast and GrobioticTMAE tended (P = 0.15) to be higher than that of fish 
fed the basal diet (Table 9). Serum lysozyme was highly variable, with no significant 
differences observed among the various dietary treatments (Table 9). Intracellular 
superoxide anion production of head kidney macrophages was not affected by the dietary 
factors in this experiment; however, extracellular superoxide anion production was 
observed to be significantly higher in fish fed diets with brewers yeast and 1% 
GrobioticTMAE (Table 9).  
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Table 8. Performance of hybrid striped bass fed diets containing various amounts of dried 
brewers yeast and GrobioticTMAE for 7 weeks in feeding trial 1a 
Diet Weight gain  
(% of initial wtb) 
Feed efficiency  
(g gain/g feed) 
Survival (%) 
Basal  388 0.93 b 92.3 
1% Brewers yeast 388 0.95 ab 100 
2% Brewers yeast 404 0.95 ab 93.8 
1% GrobioticTMAE 420 1.0 a 95.4 
2% GrobioticTMAE 405 1.0 a 96.9 
    
Pr > F c 0.45 0.05 0.28 
pooled se 5.97 0.21 1.20 
         a Values represent means of five replicate groups. Values in a column that do not have the 
same superscript are significantly different at P≤ 0.05 based on Duncan’s multiple range 
test. 
      b Fish initially weighed 7.0 ± 0.3 g each. 
      c Significance probability associated with the F statistic
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3.3 Bacterial challenge 
The disease challenge with live S. iniae resulted in approximately 50% mortality 
of fish fed the basal diet after 19 days. Survival of fish fed diets containing 
GrobioticTMAE or brewers yeast was significantly (P< 0.01) higher than fish fed the basal 
diet after the same period (Fig. 2). The moribund fish showed typical symptoms of S. 
iniae including extremely erratic swimming, cloudness in eyes, hemorrhages around 
mouth and base of fins, dark pigmentation and slow acceptance or refusal of feed. No S. 
iniae was isolated from the brain of surviving fish, while colonies of S. iniae were 
isolated from dead fish.  
 
4. Discussion 
The concept of prebiotics arose from the observation that inulin and oligofructose 
selectively stimulate the growth of bifidobacteria, which are considered to be beneficial 
to human health (reviewed by Blaut, 2002; Teitelbaum and Walker, 2002). Other 
substances including mannan oligosaccharides (White et al., 2002) and lactose (Szilagyi, 
2002) also have been reported to possess prebiotic functions in humans and/or terrestrial 
animals. Such information on prebiotics in aquatic organism is very limited. Olsen et al. 
(2001) observed that a diet supplemented with 15% inulin caused harmful effects to 
Arctic charr. However, their previous studies (Ringø et al., 1998; Ringø and Olsen, 1999) 
showed that dietary fatty acids and carbohydrates altered the bacterial flora of the 
gastrointestinal tract of fish. In this present study, the commercial prebiotic, 
GrobioticTMAE, significantly enhanced feed efficiency, immunogical responses and 
resistance of hybrid striped bass to Streptoccocus iniae infection. The beneficial influence  
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Fig 2.  Percent cumulative survival rate of hybrid striped bass fed incremental levels of 
GrobioticTMAE and brewers yeast (1 and 2%) for 4 weeks and subsequently exposed to S. 
iniae bath (P < 0.01). Symbols represent means of three replicate tanks per treatment. 
Pooled SE was 3.10.  
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of GrobioticTMAE on growth was possibly due to alteration of the intestinal microflora by 
mannan oligofructose, lactose or other carbonhydrates from the dairy ingredient, partially 
autolyzed yeast and/or dried fermentation products; however, a detailed study intestinal 
microbiology is needed. Lactic acid bacteria have been considered beneficial residents of 
the fish’s intestinal ecosystem by producing bacteriocins, which inhibit growth of certain 
fish pathogens and thus positively affect the host’s microflora (Ringo et al., 1998). Some 
reports have shown that lactose, as well as other prebiotic ingredients, may promote the 
maintenance of lactic acid-producing bacteria and prevent the expansion of potential 
pathogens in certain human diseases (Szilagyi, 2002). However, the hypothesis needs to 
be tested by further studies in fish.    
Brewers yeast has been recognized to have potential as a substitute for live food 
in the production of certain fish (Nayar et al., 1998) or as a potential replacement for fish 
meal (Rumsey et al., 1991; Oliva-Teles and Goncalves, 2001). As a protein feedstuff, 
brewers yeast has been included in commercial diet formulations for several fish species, 
including salmonids (National Research Council, 1993). The cell walls of yeast also may 
provide very important non-nutritive compounds that may benefit fish health, including 
mannose polymers covalently linked to peptides (mannoprotein), glucose polymers 
(glucans), chitin in minor amounts (Cabib et al., 1982) as well as nucleic acids (Rumsey 
et al., 1992). The beneficial influence of glucans has been demonstrated with various fish 
species (Verlhac et al., 1998; Sahoo and Mukherjee, 2002; Couso et al., 2003). Enhanced 
immunogical responses including respiratory burst also have been reported for dietary 
chitin (Esteban et al., 2001). According to Rumsey et al. (1992) and Cabib et al. (1982), 
yeast cells provide about 7.7% crude glucan and 1% chitin. It is known that glucan is 
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capable of enhancing innate immune responses, including respiratory burst of head 
kidney macrophages, serum complement activity and serum lysozyme (Engstad et al., 
1992; Jørgensen et al., 1993) when administered by injection. However, the increase of 
serum lysozyme was not observed in fish orally administered glucan or chitin (Verlhac et 
al., 1998; Esteban et al., 2001; Ortuño et al., 2002), which agrees with results of the 
present study. Serum lysozyme activity of hybrid striped bass in the present study varied 
greatly among individual fish. A similar observation was reported in a previous study 
with hybrid striped bass after 8 and 16 week of feeding with diets supplemented with 
brewers yeast (Li and Gatlin, 2003). Jorgensen et al. (1993) observed rainbow trout 
injected with 1% β- 1,3 -glucan showed significantly enhanced extracellular superoxide 
anion production of head kidney cells. Results of the present study showed that 
extracellular superoxide anion production of head kidney macrophages of hybrid striped 
bass also could be activated by oral administration of glucan and/or chitin from brewers 
yeast.  
Nucleic acids, accounting for 12-20% of the total nitrogen of brewers yeast, are 
found primarily in the purine and pyrimidine bases of nucleoproteins (Rumsey et al., 
1992). Rumsey et al. (1992) observed that supplementation of RNA extract from brewers 
yeast elevated the level of hepatic nucleic acids in rainbow trout and assumed that dietary 
nucleic acids could be incorporated into the tissue pool. However, detailed information 
on digestion and absorption of nucleic acids by fish is still limited. In recent years, a 
growing number of reports have indicated that oral administration of nucleotides is 
capable of enhancing immune responses and/or diseases resistance in several fish species, 
including hybrid striped bass (Burrells et al., 2001; Sakai et al., 2001). The extent to 
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which hybrid striped bass are capable of utilizing nucleic acids from brewers yeast and 
their contribution to enhancement of immune responses and disease resistance needs to 
be investigated further. In the present study, GrobioticTMAE and brewers yeast influenced 
immune response in very similar ways. The specific mechanism(s) by which these 
compounds exerted their beneficial influence remains unknown, although intestinal micro 
flora is recognized as a major determinant for the development of the immune system 
(Blaut, 2002). 
Disease associated with S. iniae represents a serious health and economic problem 
in cultured fish species, with an annual economic loss estimated at greater than $150 
million world wide (Buchanan et al., 2003). In North America, the hybrid striped bass 
industry has been particularly impacted (Buchanan et al., 2003). In the present study, 
survival of hybrid striped bass fed brewers yeast and GrobioticTMAE after S. iniae 
challenge was significantly higher than fish fed the basal diet. This demonstrates the 
potential of dietary strategies in reducing the risk of disease, which is generally 
associated with aquaculture. Recent progress in identification of virulence genes of S. 
iniae and development of gene vaccines against this pathogenic bacterium for hybrid 
striped bass would contribute greatly to reducing its impact in aquaculture (Buchanan et 
al., 2003). GrobioticTMAE and brewers yeast also hold promise of promoting fish health 
and resistance to infection from other pathogenic organism. Fattal-German and Bizzini 
(1992) observed the antiviral property of oral administration of live yeast cells in mice. 
This phenomenon is also worth exploring in fish as well as challenging with other 
pathogens in future. With the increasing concerns about use of antibiotics in aquaculture, 
various pre- and pro-biotics that have shown potential as alternative treatments 
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(Nikoskelaiken et al., 2001; reviewed by Irianto and Austin, 2002) should receive further 
consideration. How to utilize dietary strategies and prebiotics to maximize the efficiency 
of probiotics is a promising subject and more research is warranted.     
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CHAPTER IV 
 
EVALUATION OF THE PREBIOTIC GROBIOTIC®-A AND BREWERS YEAST 
AS DIETARY SUPPLEMENTS FOR SUB-ADULT HYBRID STRIPED BASS 
(Morone chrysops × M. saxatilis) CHALLENGED IN SITU WITH Mycobacterium 
marinum* 
 
1. Introduction 
Rapid growth and disease resistance of aquacultured organisms are two of the 
most important concerns. Traditionally, antibiotics have been supplemented in aquafeeds 
for prevention and/or treatment of bacterial disease of aquatic animals. It has been 
reported that antibiotics may enhance growth and feed efficiency by killing intestinal 
microflora and thus increasing amino acid utilization by the host in some animal species 
(Rawles et al., 1997). However, the use of antibiotics may pose threats such as 
development of bacterial strains that are more resistant to antibiotic treatment, or the 
occurrence of antibiotic residues in cultured organisms for human consumers (FAO, 
2002). Increasing concerns of antibiotic use have resulted in a ban on subtherapeutic 
antibiotic usage in Europe and the potential for a ban in the United States and other 
countries (Patterson and Burkholder, 2003). These alterations in policy may impact 
aquaculture and therefore prompt interest in developing alternative strategies for disease 
control. Beside vaccine development, dietary supplements including probiotics,  
 
 
* Reprinted from Aquaculture, Vol 248, Li, P., Gatlin, D. M. III, Evaluation of the prebiotic 
GroBiotic®-A and brewers yeast as dietary supplements for sub-adult hybrid striped bass 
(Morone chrysops × M. saxatilis) challenged in situ with Mycobacterium marinum, pp. 197-
205, Copyright 2005, with permission from Elsevier Science.   
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prebiotics and immunostimulants have received heightened attention. A rapidly 
expanding body of literature has been established that many intestinal microbial species  
may have beneficial influences on the performance of fish (reviewed by Irianto and 
Austin, 2002), and dietary composition is capable of influencing the intestinal microflora 
of fishes (Ringø et al., 1998; Ringø and Olsen, 1999). However, development of 
prebiotics, classified as “nondigestible food ingredients that benefically affect the host by 
stimulating growth and/or activity of a limited number of bacteria in the intestine”, is in 
its infancy with fishes, compared to the progress that has been made in development of 
prebiotics for poultry (Patterson and Burkholder, 2003). In a previous evaluation of the 
commercial prebiotic, GroBiotic®-A, a mixture of partially autolyzed brewers yeast, dairy 
ingredient components and dried fermentation products, significantly enhanced feed 
efficiency of juvenile hybrid striped bass was observed (Li and Gatlin, 2004a), although 
the dynamics of the intestinal microflora was not defined in that study. Supplementation 
of this prebiotic also enhanced respiratory burst of head kidney leucocytes and resistance 
against Streptococcus iniae infection; however, the interpretation of these beneficial 
influences was complicated by the presence of brewers yeast, which is generally 
considered to be an immunostimulant for fishes (Siwicki et al., 1994; Ortuño et al., 2002; 
Li and Gatlin, 2003; Rodríguez et al., 2003).     
The hybrid striped bass is an important fish for U.S. aquaculture, but it is affected 
by several pathogenic bacteria such as Streptococcus iniae, Aeromonas hydrophila and 
Mycobacterium marinum (reviewed by Plumb, 1997). With limited availability of 
approved therapeutic compounds and the inconvenient and costly administration of 
vaccines, this fish has been used in our laboratory as a model for investigating the 
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interaction between diet and disease resistance. Besides Streptococcus iniae, the 
prevalence of mycobacteria in wild striped bass and cultured hybrid striped bass has 
attracted increased attention (Gauthier et al., 2003; Overton et al., 2003). Although 
mycobacteriosis is generally chronic, this disease may cause severe infection and high 
cumulative mortality in closed, recirculating systems (Plumb, 1997). In addition, this 
bacterium is reported to be capable of surviving under many adverse environmental 
conditions, including low temperature, and may cause infection on the extremities of 
humans (Plumb, 1997; Mediel et al., 2003). A recent report of the presence of 
mycobacteria in frozen seafood also raised concern about the safety of such seafood for 
human consumers (Mediel et al., 2003). Currently, effective treatment of this disease is 
very limited as reported for other fish species (Colorini et al., 1998). Therefore, the 
present study was conducted to explore growth performance and non-specific immune 
responses of sub-adult hybrid striped bass fed the dietary prebiotic, GroBiotic®-A and 
brewers yeast under conditions of chronic exposure to Mycobacterium marinum. 
 
2. Materials and Methods 
2.1 Experimental diets 
The basal diet was formulated from practical feedstuffs obtained at a commercial 
feed mill (Rangen Inc. Angleton, TX) to contain 40% protein, 10% lipid and an estimated 
digestible energy level of 3.5 kcal/kg (Table 10). This diet satisfied and/or exceeded all 
known nutrient requirements of hybrid striped bass (Gatlin, 1997; Webster, 2002) or 
other warmwater fishes (National Research Council, 1993). Partially autolyzed brewers 
yeast (Brewtech®) and GroBiotic®-A, a mixture of partially autolyzed brewers yeast,  
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Table 10. Composition of experimental diets 
Constituent Basal diet 1% Brewers 
yeast 
2% Brewers 
yeast 
2% GroBiotic®-
A 
Ingredient (% dry weight) 
Menhaden fish    
meal a 34.7 34.4 34 34
Soybean meal a 32.6 32.3 31.9 31.9
Wheat flour a 31.3 31 30.7 30.7
Menhaden fish 
oil b 5 5 5 5
Salt a 1.1 1.1 1.1 1.1
Mineral/vitamin 
premix a 0.3 0.3 0.3 0.3
Brewers yeast c 0 1 2 0
GroBiotic®-A c 0 0 0 2
Analyzed proximate composition (% dry matter) e 
Moisture 4.3 3.5 6.0 4.4
Crude protein 
(N×6.25) 41.2 38.6 39.1 40.8 
Crude lipid 9.0 9.1 9.0 9.1
Ash 9.5 9.7 9.5 9.6
a Rangen Inc. Angleton, TX.  
b Omega Protein Corporation, Reedville, VA. 
c International Ingredient Corporation, St. Louis, MO. Contained 51.0 % crude protein 
and 1.1 % crude lipid (dry-weight basis). 
d International Ingredient Corporation, St. Louis, MO. Contained 35.2 % crude protein, 
1.7 % crude lipid and ~53% simple and complex carbohydrates including oligosaccharide 
(dry-weight basis). 
e Means of two analyses.  
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dairy ingredient components and dried fermentation products, were supplied by 
International Ingredient Corporation (St. Louis, MO, USA). Two incremental levels (1 
and 2% of diet) of brewers yeast and 2% of GroBiotic®-A were added to the basal diet 
 (Table 10). In addition, 5% menhaden fish oil (Omega Protein Corp., Reedville, VA) 
was added prior to extrusion processing as described by Rawles and Gatlin (2000) to 
produce neutrally buoyant 5-mm pellets. Diets were stored in sealed bags in a 
temperature-controlled room at 22 ± 2 oC until fed.   
 
2.2 Feeding trial 
Juvenile hybrid striped bass (Morone chrysops × M. saxatilis) were obtained from 
a commercial supplier (Keo Fish Farm, Keo, AR) and maintained in an earthen pond at 
the Texas A&M University Aquacultural Research and Teaching Facility prior to the 
feeding trial. Three fish were randomly obtained from this population and analyzed by 
the Texas Veterinary Medical Diagnostic Laboratory (TVMDL) to confirm they were 
pathogen-free by routine culture and histopathology. The culture system consisted of 16, 
1134-l round fiberglass tanks connected as a closed recirculating system to a settling 
chamber and biological filter. This system had held hybrid striped bass with a severe 
mycobacteria infection shortly before the present feeding trial. Fish were seined from the 
pond, transported to the culture system and fed the basal diet to apparent satiation twice 
per day for a 2-week conditioning period. Fish were then graded by size and 12 groups of 
50 fish averaging 64.5 g each with a total weight of 3225 ± 142 g (mean ± SD) per group 
were stocked into individual tanks and four groups of 50 fish averaging 118 g with a total 
weight of 5900 ± 81 g (mean ± SD) per group were stocked in the remaining tanks, 
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according to a randomized complete block design. Water flow rate was maintained at 
approximately 2 l/min via a recirculating system which maintained adequate water 
quality through biological and mechanical filtration. Salinity was maintained at 2-3‰ 
using well water and synthetic sea salt (Fritz Industries Inc., Dallas, TX). Low pressure 
electrical blowers provided aeration via air stones and maintained dissolved oxygen (DO) 
levels between 4 and 6 mg/l. Water temperature was controlled by conditioning the 
ambient air in the building and remained at 26 ± 1 oC throughout the trial. A 12 h light: 
12h dark photoperiod was maintained with fluorescent lights controlled by timers.  
Each experimental diet was fed to three groups of small fish and one group of 
large fish for 16 weeks. All groups were fed to apparent satiation in the morning and 
evening, 7 days each week. Growth and feed efficiency were monitored monthly by 
collectively weighing each group of fish. Weight gain was expressed as the increase in 
total cumulative biomass per tank. After week 16, a chronic mycobacterial infection 
become severe and was confirmed by the TVMDL to be caused by Mycobacterium 
marinum by biochemical analysis. At that, fish were fed to apparent satiation once per 
day for additional 5 weeks. Mortality was monitored twice daily during this period. All 
procedures were approved by the Animal Care and Use Committee of Texas A&M 
University. 
 
2.3 Sample collection and analysis 
At the end of the feeding trial, three apparently healthy fish (no obvious skin 
lesions and visceral granulomas) from each tank were anesthetized with tricaine methane 
sulfonate (MS-222), and approximately 2 ml of blood was collected from the caudal 
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vasculature using a 3-ml syringe and 23-gauge needle. These representative fish were 
euthanized and head kidney samples were pooled for macrophage isolation and assay of 
respiratory burst of head kidney leukocytes. The assay of extracellular and intracellular 
superoxide anion followed the procedure of Secombes (1990), as modified by Sealey and 
Gatlin (2002a). The amount of extracellular superoxide anion was calculated by the 
formula of Pick and Mizel (1981). Whole blood neutrophil oxidative radical production 
was determined as described by Siwicki et al. (1994). Absorbance was converted to nitro 
blue tetrazolium (NBT) units based on a standard curve of NBT diformazan/ml blood. 
Plasma was separated as previously decribed (Li and Gatlin, 2003) and lysozyme activity 
was determined by a turbidimetric assay (Jørgensen et al., 1993). A lysozyme activity 
unit was defined as the amount of enzyme producing a decrease in absorbance of 0.001 
min-1 at pH 6.1. Serum peroxidase was analyzed as described by Rodríguez et al. (2003).  
 
2.4 Statistics 
    Data from the feeding trial, immune response assays and the bacterial challenge 
were subjected to analysis of variance according to a randomized complete block design 
using a significant level of P ≤ 0.05. If a significantly main effect was observed, 
treatment means were separated using the LSD comparison test. All statistical analysis 
was conducted with Statistix® Analytical Software (Tallahassee, FL).  
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3. Results 
3.1 Growth performance 
Generally, fish fed the diets supplemented with brewers yeast and GroBiotic®-A  
had better growth performance during the 16-week feeding trial (Table 11). After 4 
weeks of feeding, fish fed 2% brewers yeast had a significantly (P <0.05) higher weight 
gain than fish fed the basal diet and the diet supplemented with 2% GroBiotic®-A. After 
12 weeks, fish fed 1 and 2% brewers yeast and 2% GroBiotic®-A had significantly  
higher weight gain than fish fed the basal diet, and feed efficiency showed a similar trend. 
At the end of the 16-week period, fish fed 2% brewers yeast and GroBiotic®-A had the 
highest biomass, which tended to be significant (P=0.11). Feed efficiency of fish fed 2% 
brewers yeast was significantly greater than the other treatments.   
 
3.2 Immune response assays 
No significant effects of the various diets were observed on neutrophil oxidative 
radical production, serum lysozyme and intracellular superoxide anion production by 
head kidney macrophages of sub-adult hybrid striped bass after the 16-week period 
(Table 12). However, fish fed 1 and 2% brewers yeast had a significantly (P<0.01) 
higher serum peroxidase level than fish fed the basal diet and the diet supplemented with 
2% GroBiotic®-A diet. The extracellular superoxide anion production of head kidney 
macrophages of fish fed the basal diet was significantly higher compared to fish fed diets 
supplemented with 1% brewers yeast and 2% GroBiotic®-A (Table 12).  
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3.3 Bacterial challenge 
The survival of fish in the feeding trial decreased over time as the severity of the 
mycobacterial infection increased. This in situ mycobacterial challenge resulted in 
approximately 25% mortality over the 21-week period. Fish fed the diets with 1% 
brewers yeast and 2% GroBiotic®-A had enhanced survival (P<0.05) at the 8-, 12- and 
16-week intervals (Fig. 3). At the end of the 21-week period, survival of fish fed 2% 
GroBiotic®-A was significantly higher than fish fed the basal diet and brewers yeast 
supplemented diets (Fig. 3).  Typical signs of mycobacterial infection including  
granulomas in the spleen, head kidney and a pale granulomatous liver with rough 
granular surface after necropsy as well as ulcerations and hemorrhaging in the skin were 
observed in moribund fish. The cause of mycobacteria was confirmed by the TVMDL via 
bacterial isolation and histopathology.  
 
4. Discussion 
Mycobacterial species have been known for years to be capable of infecting many 
fish species in both fresh water and seawater (Frerichs, 1993; Plumb, 1997; dos Santos et 
al., 2002). Striped bass and hybrid striped bass may be one of the most susceptible 
species based on increasing case reports in recent years (Gauthier et al., 2003; Harms et 
al., 2003; Overton et al., 2003). Although the presence of mycobacteria is rather common 
in wild fish populations, it has become one of the most serious infections in intensive, 
recirculating culture systems (Plumb, 1997). Besides the economic need for developing 
anti-mycobacteriosis strategies, the chronic progression of this disease provided an 
opportunity to explore growth and immune responses of hybrid striped bass fed different  
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immunostimulants. Because water has long been recognized as a primary source for 
mycobacterial transmission (Goslee and Wolinsky, 1976; dos Santos et al., 2002; 
Gauthier et al., 2003), chronic exposure to mycobacteria-contaminated water was 
employed in this trial to mimic a natural infection and to prevent possible excessive 
mortality from acute inflammation, although experimental mycobacterial infections 
traditionally have been conducted by intramuscular (Wolf and Smith, 1999) or 
intraperitoneal injections (Colorni et al., 1998; Gauthier et al., 2003), which have been 
used for research on pathology and immunology associated with this disease.   
Increased weight gain and feed efficiency were generally observed in hybrid 
striped bass fed diets supplemented with partially autolyzed brewers yeast and 
GroBiotic®-A at each sampling time (4, 8, 12 and 16 weeks). However, variation within 
treatments complicated the interpretation of these data. Fish fed the diet supplemented 
with 2% brewers yeast had consistently and significantly better growth performance 
throughout the feeding trial compared to fish fed the diets. To the best of our knowledge, 
this is the first time to report that dietary supplementation of inactivated or autolyzed 
brewers yeast could serve as growth enhancer under certain conditions such as chronic 
infection, although biologically-active brewers yeast had been reported to serve as a 
probiotic and enhanced growth of tilapia (Lara-Flores et al., 2002). Feed efficiency of 
every dietary treatment decreased over time in the present study. It is speculated that this 
reduction was correlated with the severity of the mycobacterial infection. With the 
progression of the mycobacterial infection, inflammation was induced and immune 
responses were upregulated accordingly. Increased expense for growth would be 
expected as a consequence of dramatically increased requirement for amino acids to 
 56
synthesize differentiated proteins for immune functions, substrates for nitric oxide 
production (arginine) and energy for macrophages and lymphocytes (glutatmine). It also 
was noted that weight gain of fish fed all experimental diets decreased between week 12 
and 16. Although progress of mycobacteriosis could possibly suppress feed intake and 
increase the cost of growth, overaccumulation of metabolic wastes such as ammonia (up 
to 10.6 mg/l) and nitrite (up to 1.2 mg/l) may have contributed more to the undermined 
feed intake and subsequently reduced growth, because the concern of spreading this 
bacterium through effluent restricted the exchange of water between system and 
environment.  
A previous study in our laboratory showed that feeding a diet supplemented with 
brewers yeast for 16 weeks could increase blood neutrophil oxidative radical production 
and extracellular superoxide anion production of head kidney leucocytes of juvenile 
hybrid striped bass (Li and Gatlin, 2003). This present study failed to support our 
previous observation, possibly due to the masking effect of inflammation induced by 
mycobacterial infection, if no difference in age/size responses to immunostimulation by 
dietary supplements was involved. At the end of 16 weeks, over 50% of hybrid striped 
bass in the trial were observed to have skin ulcerations and hemorrhages, suggesting a 
high prevalence of mycobacterium in the present study. Although only apparently healthy 
fish were sampled for immune response assays, mycobacteria-infected fish sometimes 
showed rather normal appearances (Gauthier et al., 2003). This uncertainty in infection 
status compromised the conclusiveness of data from the immune response assays. Fish 
fed diets supplemented with 1 or 2% brewers yeast for 16 weeks had a significantly 
higher serum proxidase level compared to fish fed the basal diet and diet supplemented 
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with GroBiotic®-A. Rodríguez et al. (2003) observed that 6 weeks, but not 2 or 4 weeks 
of feeding a cell-wall modified yeast (33% glucan, 56% mannoproteins and 11% chitin) 
decreased serum proxidase level of gilthead sea bream. The effect of dietary brewers 
yeast on serum peroxidase warrants further investigation. Intracellular superoxide anion 
production of head kidney leucocytes and serum lysozyme were not affected by dietary 
treatments in the present study. However, it is noted that the serum lysozyme measured in 
the present study was dramatically higher than all the values previously published for 
hybrid striped bass (Sealey and Gatlin, 2002b; Li and Gatlin, 2003, 2004; Jaramillo and 
Gatlin, 2004; Li et al., 2004). Although serum lysozyme level of hybrid striped bass is 
influenced by genetic polymorphisms (Wang and Gatlin, unpublished data) and variation 
in genetic makeup of fish may contribute to the phenomenon, it is speculated that 
mycobacteriosis stimulated serum lysozyme level of hybrid striped bass in the present 
study. Chen et al. (1998) reported that injection of the extracellular product of 
Mycobacterium  sp induced an elevation in serum lysozyme level. Although pathology of 
mycobacteriosis is well defined, the immunological responses associated with 
mycobacterial infection are still limited. Bartos and Sommer (1981) and Harms et al. 
(2003) reported responses of cellular immunity and transforming growth factor-β 
responses associated with mycobacteriosis, respectively, but further investigation of 
potential interactions among dietary strategies, immune responses and mycobacterial 
infection is warranted.               
In the present study, dietary supplementation of prebiotic GroBiotic®-A 
significantly enhanced survival of hybrid striped bass during the in situ mycobacterial 
challenge, suggesting a potential use of this prebiotic in aquaculture. Based on knowledge 
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acquired from human and terrestrial animals, prebiotics are usually most effective against 
enteric diseases. It is known that ingestion of feed also is a port of entry for mycobacteria 
in some fish species including snakehead (Chinabut et al., 1990). This could possibly be a 
factor contributing to the positive response associated with the GroBiotic®-A supplement; 
however, efforts to characterize intestinal microbiology of fish in the present study failed. 
Research on prebiotics for human use since 1995 has established that some bacterial 
species are health-promoting and are capable of selectively utilizing non-digestible 
dietary components in the colon such as inulin and lactose (Manning and Gibson, 2004). 
Lactobacilli also have been reported to be probiotics for fishes (reviewed by Irianto and 
Austin, 2002). Positive influences of GroBiotic®-A on growth performance and disease 
resistance of hybrid striped bass in the present study showed desirable influences of 
prebiotics for aquaculture. 
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CHAPTER V 
 
DIETARY OLIGONUCLEOTIDE INFLUENCES IMMUNE RESPONSES AND 
RESISTANCE OF HYBRID STRIPED BASS (Morone chrysops×M. saxatilis) TO 
Streptococcus iniae INFECTION* 
 
1. Introduction 
    Hybrid striped bass (Morone chrysops x M. saxatilis) production is considered 
to be the fastest growing segment of the U.S. aquaculture industry over the past decade 
and has spread to several countries and regions in Europe and Asia (Harrell and Webster, 
1997; Hiney et al., 2002; Sealey and Gatlin, 2002c). This fish is intrinsically sensitive to 
various stressors and subsequently susceptible to infectious agents during normal 
aquacultural production (Plumb, 1997). In recent years, there have been growing 
concerns about the adverse effects of the bacterium Streptococcus iniae in the 
aquaculture of many economically important marine and freshwater fish species (Li and 
Gatlin, 2003). This bacterium has become one of the most threatening pathogenic 
organisms of the hybrid striped bass culture industry and is estimated to cause about $ 2 
million in economic loss in the USA every year attributable to fish mortality, poor growth 
and feed conversion, as well as the expense of therapeutic treatment which usually occurs 
multiple times (Ostland, 2003). Although positive results have come from experimental  
 
 
* Reprinted from Fish and Shellfish Immunology, Vol 16, Li, P., Lewis, D. H., Gatlin, D. M. III, 
Dietary oligonucleotide influences immune responses and resistance of hybrid striped bass 
(Morone chrysops × M. saxatilis) to Streptococcus iniae infection, pp. 561-569, Copyright 
2004, with permission from Elsevier Science.   
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treatment of this disease in tilapia with oxytetracycline (Darwish et al, 2002) and hybrid 
striped bass with enrofloxacin (Stoffregen et al, 1996), these drugs are still under  
investigation and there are currently no antibiotics approved by the U.S. Food and Drug 
Administration to treat bacterial diseases of hybrid striped bass. Therefore, 
immunonutrition may be of great promise in prevention of infectious diseases of hybrid 
striped bass such as streptococcicosis and thus warrants investigation.  
Nucleotides and their metabolites have received heightened attention in recent 
years as potential immunomodulators. They play key roles in numerous essential 
physiologic functions, including encoding genetic information, mediating energy 
metabolism and signal transduction (Carver and Walker, 1995; Aggett et al., 2003). It is 
generally assumed that the requirement for nucleotides can be met by endogenous 
metabolic pathways of synthesis and salvage. However, this is now being challenged by 
reports involving humans and terrestrial animals, which have shown that dietary 
nucleotides are capable of enhancing cell- mediated immunity, lymphocyte proliferation, 
interleukin (IL)-2 production, and improving host resistance to bacterial infection. In 
recent years, beneficial influences of oral administration of nucleotides on immune 
functions, vaccine efficiency, or disease resistance also have been demonstrated in fish 
such as Atlantic salmon (Salmo salar) (Burrells et al., 2001a, b), coho salmon 
(Oncorhynchus kisutch) (Burrells et al., 2001a), rainbow trout (Oncorhynchus mykiss) 
(Burrells et al., 2001a), common carp (Cyprinus carpio) (Sakai et al., 2001) and hybrid 
tilapia (O. niloticus × O. aureus) (Ramadan et al., 1996). However, information on 
hybrid striped bass is not available to date. Dietary brewers yeast has been proven to be 
capable of enhancing immune responses of hybrid striped bass as well as resistance to 
 61
Streptococcus iniae infection (Li and Gatlin, 2003).  However, the extent to which 
nucleotides and RNA from brewers yeast contributed to the positive influence remains 
unclear. Therefore, the present study was conducted to determine the effects of dietary 
nucleotides on specific and non-specific immune responses of hybrid striped bass and 
resistance to Streptococcus iniae infection. The efficacy of long-term oral administration 
of nucleotides also was explored by comparing various immune responses.    
 
2. Materials and Methods 
2.1. Diets 
  The basal diet, which utilized menhaden fish meal as the protein source, 
contained 40% protein, 10% lipid and an estimated digestible energy level of 3.5 kcal/g 
(Table 13).  This diet satisfied and/or exceeded all known nutrient requirements of hybrid 
striped bass (Gatlin, 1997) or other warmwater fishes (NRC, 1993). An oligonucleotide 
mixture of guanosine, adenosine, uridine and cytidine isolated from a strain of 
Saccharomyces (brewers yeast) was supplied by Ascogen P® (Canadian Bio-Systems Inc., 
Calgary, Alberta, Canada) and was supplemented at the manufacturer’s recommended 
rate of 0.5% to the basal diet. Cellulose, menhaden meal and menhaden oil were adjusted 
to provide isonitrogenous and isolipidic diets. Procedures for diet preparation and storage 
were as previously described (Rawles and Gatlin, 1998). 
 
2.2.1. Feeding trial 1 
An initial feeding trial was conducted to evaluate growth performance, non-
specific immune responses as well as disease resistance of hybrid striped bass fed the two  
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diets. Prior to initiation of this feeding trial, juvenile hybrid striped bass obtained from 
Keo Fish Farm (Keo, AR) were subjected to a 2-week conditioning period to adjust to 
standardized regimes in a recirculating culture system consisting of 38-l aquaria.  Groups 
of 15 juvenile hybrid striped bass weighing approximately 9.7 g/fish were stocked into 
individual aquaria such that initial weight averaged 142 ± 5 g/group.  The basal and 
experimental diets were both fed to four replicate groups of fish for 8 weeks.  All groups 
were fed their respective diets at the same fixed rate (initially 5% of body weight per day 
and gradually reduced to 3%) which approached apparent satiation. Growth and feed 
efficiency were monitored weekly by collectively weighing each group of fish. 
 
2.2.2. Preparation of blood and serum 
    At the end of this feeding trial, three representative fish from each aquarium 
were anesthetized with an overdose of MS-222 and blood collected from the caudal 
vasculature. After a sample of whole blood was taken for hematocrit determination, 
serum was isolated by centrifugation (3000 × g for 5 min) and kept at –80 oC. After 
bleeding, the fish were frozen for whole-body composition analysis (Rawles and Gatlin, 
1998).  
 
2.2.3. Lysozyme assay 
Serum lysozyme activity was determined by turbidimetric assay as described by 
Jorgensen et al. (1993a). A lysozyme activity unit was defined as the amount of enzyme 
producing a decrease in absorbance of 0.001 min-1.  
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2.2.4. Preparation of bacterial suspension and bath challenge 
    An additional 30 fish previously fed each of the experimental diets for a total of 
9 weeks were exposed to an estimated LD50 dose of Streptococcus iniae.  A virulent 
isolate of S. iniae originally obtained from the brain of an infected tilapia (Oreochromis 
sp.) was biochemically identified and provided by the Texas Veterinary Medicine 
Diagnostic Laboratory. The bacterial suspension was prepared according to the method 
described by Sealey and Gatlin (2002c) and diluted to a concentration of 2.6 × 105 
CFU/ml in fresh well water. Thirty fish from each dietary treatment, pooled separately in 
mesh baskets, were immersed in the bacterial suspension for 2 hours. After bacterial 
exposure, the 30 fish from each dietary treatment were divided into three groups of 10, 
and placed into 38-l aquaria in an isolated culture system that received a constant supply 
of well water at 25 ± 2 oC. Fish continued to be fed their respective diets to apparent 
satiation twice daily, and mortality was monitored for 2 weeks. Thereafter, a secondary 
bacterial exposure was conducted on surviving fish with an increased bacterial 
concentration of 1.5 × 106 CFU/ml following the procedure described by Nguyen et al. 
(2001a, b). The mortality was monitored for 3 weeks. The brains of both dead fish and 
surviving fish were streaked on modified selective agar to determine infection status and 
confirm death from S. iniae (Nguyen and Kanai, 1999). 
 
2.3.1. Feeding trial 2  
A second feeding trial was conducted to further evaluate resistance of hybrid 
striped bass fed nucleotides to Streptococcus iniae infection as well as specific immune 
responses. Groups of 13 juvenile hybrid striped bass weighing approximately 7.1 g/fish 
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were stocked into individual aquaria such that initial weight averaged 92 ± 5 g/group. 
Each diet was fed to fish in four replicate groups initially at 6% of body weight and 
gradually reduced to 2.5% of body weight over the course of the trial such that fish were 
continuously fed at a rate approaching apparent satiation. The feeding trial was conducted 
for 6 weeks. After the feeding trial, 12 fish per treatment (three fish per aquarium) were 
bled and serum was separated for lysozyme as described above and serum protein 
analyzed using Sigma Kit 690-A (Sigma, St. Louis, MO).  
 
2.3.2. Neutrophil oxidative radical production assay 
 Neutrophil oxidative radical production was determined following the procedure 
described by Siwicki et al. (1994). Absorbance was converted to Nitro Blue Tetrazolium 
(NBT) units based on a standard curve of NBT diformazan/ml blood.  
 
2.3.3. Bacterial challenge 
An additional 30 fish previous fed each diet for a total 7 weeks were exposed to S. 
iniae at a concentration of  8.4 x 105 CFU/ml in fresh well water following the previously 
described procedure. Fish continued to be fed their respective diets to apparent satiation 
once daily and mortality was monitored for 3 weeks.  
 
2.3.4. Specific immune function sampling 
Eight surviving fish from each treatment were chosen randomly and injected with 
S. iniae intraperitoneally 3 weeks after first exposure to S. iniae. The bacterial suspension 
was prepared by the procedure described by Sealey and Gatlin (2002c) at a concentration 
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of 6 × 106 CFU/ml. Three fish fed the basal diet died within 10 days after immunization 
but all fish fed the nucleotide-supplemented diet survived. All the surviving fish were 
bled at day 10 after immunization and serum was separated as previously described. Slide 
agglutination and microtitration agglutination were used to test for antibody presence in 
the serum following the procedure described by Roberson (1991). A positive reaction 
was described by the presence of a button with fuzzy edges; whereas, a negative reaction 
consisted of a round precipitate with clearly defined circular margins (Sealey and Gatlin, 
2002a). Antibody titer was expressed as the reciprocal log base 2 of the highest dilution 
demonstrating a positive reaction.     
 
2.4.1. Feeding trial 3 
A separate feeding trial was conducted to further evaluate the efficacy of long-
term administration (16 weeks) of nucleotides on immune functions. Fifteen fish 
weighing approximately 10 g/fish were stocked into each of two 38-l aquaria in the same 
system as Trial 1 and fed either the basal or nucleotide-supplemented diets. During the 
first 8 weeks, both groups of fish were fed their respective diets twice daily at the same 
fixed rate (initially 5% of body weight per day and gradually reduced to 3%). In the 
second 8 weeks, both groups of fish were fed once daily to apparent satiation. After 16 
weeks of feeding, four fish from each treatment were bled. Neutrophil oxidative radical 
production and serum lysozyme were determined as previous described. Eight fish per 
treatment were euthenized and head kidney samples were taken for leukocyte isolation.  
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2.4.2. Leukocyte isolation and superoxide anion production assay 
This assay followed the procedure described by Secombes (1991) with minor 
modifications by Sealey and Gatlin (2002a). The amount of extracellular superoxide 
anion was calculated from the formula: nanomoles superoxide anion per well = (∆ 
absorbance after 60 min × 100)/6.3 (Pick and Mizel, 1981). 
 
2.5. Statistics 
    Data from all feeding trials and bacterial challenges were subjected to Student’s 
t-test using the Statistical Analysis System (SAS, 1985).  Differences in treatment means 
were considered significant at P < 0.05. 
 
3. Results 
3.1. Feeding trial 1 
In trial 1, no significant differences were observed in weight gain or feed 
efficiency and survival of fish fed the basal diet and nucleotide-supplemented diet (Table 
14) and survival averaged 97% over the 8-week period. Hematocrit and serum lysozyme 
averaged 46.4% and 923 uits/L, respectively, with no significant effects of dietary 
nucleotide supplementation observed. Whole-body composition (moisture, crude protein, 
lipid and ash) also was not significantly affected by dietary supplementation of 
nucleotides. Generally lower mortality was observed in fish fed the nucleotide-
supplemented diet after initial S. iniae exposure; however, in the secondary challenge, 
significant differences in mortality between fish fed the basal diet and the nucleotide-
supplemented diet were evident (Table 14). No S. iniae was isolated from the brain of  
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surviving fish, while colonies of S. iniae were isolated from dead fish.   
 
3.2. Feeding trial 2 
Fish fed the nucleotide-supplemented diet tended (P<0.1) to have greater weight 
gain than those fed the basal diet (Table 15). No differences were observed in feed 
efficiency, survival or serum protein concentration (Table 15). Significant enhancement 
in blood neutrophil oxidative radical production of fish fed the nucleotide-supplemented 
diet was observed (Table 15). During the 3 weeks after bath challenge with S. iniae, 40% 
mortality was observed in fish fed the basal diet, while only 13.3% mortality occurred in 
fish fed the nucleotide-supplemented diet (P<0.1). After the booster injection, five out of 
eight fish fed the basal diet and all 8 fish fed the nucleotide-supplemented diet survived. 
Although strong agglutination responses were observed only in fish fed the nucleotide-
supplemented diet, the antibody titers were not significantly different because no 
detectable levels of antibody were observed in some fish fed each diet (Table 15).     
 
3.3. Feeding trial 3  
Blood neutrophil oxidative radical production, extracellular and intracellular 
superoxide anion production of head kidney leukocytes and serum lysozyme were 
measured after 16 weeks of feeding each diet. No significant differences in these 
responses were observed between fish fed the two diets (Table 16). 
 
4. Discussion 
Nucleotides have been generally considered as non-essential nutrients because 
deficiency signs have not been observed (Carver and Walker, 1995). It is now known that  
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tissues such as intestinal mucosa, bone marrow hematopoietic cells, lymphocytes and the 
brain have limited capacity for de novo nucleotide synthesis and depend on the supply by 
the salvage pathway (Yamauchi et al. 2002). Therefore, Yamauchi et al. (2002) raised the 
hypothesis that the endogenous supply of nucleotides may not be adequate for optimal 
functioning, especially of the immune system, under stressful conditions such as sepsis 
and trauma, and thus a dietary supply may be of particular significance. Aquacultural 
production undoubtedly may create compromising environments for the target organism, 
where stressors caused by handling, grading, transporting, poor water quality, 
overcrowding and diseases are typically common.  It appears reasonable to supplement 
exogenous nucleotides to the normal diets of aquacultured organisms, although 
information pertaining to the synthesis and metabolism of nucleotides in lower 
vertebrates such as fish and invertebrates such as crustaceans is extremely limited to date. 
Although the nutritional value of nucleotides to humans and other animals is still in some 
dispute, the results from studies on fish appear to be rather consistent. To our best 
knowledge, all published results in fish including this present study showed that oral 
administration of nucleotides enhanced host resistance to pathogens (Burrells et al., 
2001a, b; Sakai et al., 2001). However, the mechanism(s) behind this beneficial influence 
is not clear.  
In this present study, neutrophil oxidative radical production of hybrid striped 
bass fed the nucleotide-supplemented diet was significantly higher than that of fish fed 
the basal diet after 8 weeks. Matsumoto et al. (1995) observed that a mixture of 
nucleosides and nucleotides increased the peripheral neutrophil number in mice. 
Although some reports showed that dietary nucleotides can increase macrophage function 
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in the rat (Carver, 1994), the respiratory burst of macrophages in fish did not show 
consistent results. In present study and that of Burrells et al. (2001a), no enhancement of 
respiratory burst head kidney macrophage was observed. However, Sakai et al. (2001) 
observed that oral administration of nucleotides resulted in enhanced phagocytic and 
NBT responses in kidney phagocytic cells of common carp for more than 10 days post-
treatment. In that study (Sakai et al., 2001), serum lysozyme activity and serum 
complement of common carp orally administered nucleotides were significantly higher 
than that of fish fed a basal diet. In the present study, serum lysozyme appeared to be 
unaffected by dietary nucleotides at administration intervals of 7, 8 and 16 weeks.  
Burrells et al. (2001a) reported beneficial effects of dietary nucleotides when 
challenging salmonids with infectious salmon anaemia virus, Vibrio anguillarum, 
Piscirickettsia salmonis and sea lice. They hypothesized that dietary nucleotides are 
capable of enhancing the potential of the immune system in general to mount greater and 
more rapid specific responses, as compared to the primarily non-specific capacity of 
phagocytes induced by glucan. This hypothesis was supported by other reports on 
Atlantic salmon (Burrells et al., 2001a) and hybrid tilapia (Ramadan et al., 1994) fed 
nucleotide-supplemented diets. Atlantic salmon were reported to have an enhanced 
efficacy of vaccination based on comparing antibody titers and survival rate (Ramadan et 
al., 1994). Similarly, a marked rise in the geometric mean of antibody titers after 
vaccination was observed in tilapia (Ramadan et al., 1994). In addition, dietary 
nucleotides have been observed to modulate gene expression (Sanchez-Pozo and Gil 
2002), a phenomenon also confirmed in fish by Low et al. (2003). However, the way in 
which dietary nucleotides modulate gene expression during development of adaptive 
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immunity is still not clear. In the present study, the most significant enhancement in 
survival of hybrid striped bass fed nucleotide-supplemented diet was observed after S. 
iniae reexposure. It is possible that dietary nucleotides contribute to the development of 
the specific immune response. In Trial 2, antibody titer also tended to be higher in hybrid 
striped bass fed the nucleotide-supplemented diet. This result also supports the hypothesis 
of Jyonouchi et al. (1993, 1994) and Navarro et al. (1996) that dietary nucleotides exert 
the greatest impact on the immune system by modulating Ig production.  
It is generally recognized that dose and timing have important effects on the 
efficacy of immunostimulants. Because most publications on nucleotide supplementation 
to fish have used patented commercial products, information pertaining to concentration 
and ratio of various types of nucleotides are generally unavailable. Therefore, it is very 
difficult to quantitatively estimate or compare the effects of supplemented nucleotides on 
the immune responses of various fish species. In the present study with hybrid striped 
bass, no significant differences in blood neutrophil oxidative radical production, or 
intracellular and extracellular superoxide anion production of head kidney leukocytes 
were observed after 16 weeks of feeding the nucleotide-supplemented diet while 
neutrophil oxidative radical production of fish fed this diet was significantly higher than 
that of fish fed the basal diet after 8 weeks. This may have been due to difference in the 
timing of administration of the nucleotide-supplemented diet or changes in the 
requirement for exogenous nucleotides as a function of fish size.  
The study of Ramadan and Atef (1991) showed that dietary nucleotides 
significantly enhanced weight gain of tilapia. However, this phenomenon was not 
noticeable in all of the feeding trials of the present study, although higher weight gain 
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tended to be observed in fish fed the nucleotide-supplemented diet in Trial 2.  
It is concluded that dietary oligonucleotides positively influenced non-specific 
immune response and resistance of juvenile hybrid striped bass to S. iniae. However, 
there are gaps in our knowledge about exogenous nucleotides in fish concerning 
absorption, metabolism, modulation of immunoglobulin production, age/size-related 
response and appropriate doses or time of intakes. Therefore, further investigation in 
these areas is warranted. 
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CHAPTER VI 
 
EVALUATION OF LEVAMISOLE AS A DIET SUPPLEMENT FOR GROWTH 
AND HEALTH MANAGEMENT OF HYBRID STRIPED BASS (Morone chrysops 
× M. saxatilis) 
 
1. Introduction 
For decades, antiobiotics have been extensively used to treat illness, prevent 
infections or promote growth in animal production. However, concerns on the part of the 
scientific community and general public about development of antibiotic-resistant 
bacterial strains are strongly challenging the use of antiobiotics in agriculture (FAO, 
2002). These concerns have been heightened by the occasional cases of human death 
from antibiotic-resistant bacteria reported in recent years (Ferber, 2000). Therefore, the 
potential uses of existing antibiotics and approval of new ones for aquaculture may be 
limited. Research on interactions between nutrition and immunity and the development of 
alternatives to antibiotics that may keep fish healthy such as probiotics, prebiotics and 
immunomodulators is receiving heightened attention in aquaculture nutrition and 
aquafeed research.  
Hybrid striped bass is an important economic fish species in the USA. Although a 
wide range of pathogenic organisms in hybrid striped bass have been described (Plumb, 
1997), the major pathogens threatening this industry are several bacteria, especially 
Streptococcus iniae, Aeromonas hydrophila and mycobacterial species (Ostland, 2003). 
Because disease prevention and treatment strategies such as use of vaccines and drugs are 
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currently limited in hybrid striped bass aquaculture due to regulatory constraints or 
excessively burdensome administration protocols, extensive effort has been expended in 
screening a variety of recognized immunonutrients and immunostimulants to develop 
practical dietary immunotherapies for hybrid striped bass against those bacteria (Sealey 
and Gatlin, 2002a; Li and Gatlin, 2003; 2004; Li et al., 2004; Jaramillo and Gatlin, 2004). 
Levamisole is a synthetic antihelminthic drug for protecting terrestrial animals 
against stomach, intestinal and lung worms (JECFA, 1991). It was the first drug reported 
to increase the functions of cellular immunity in healthy laboratory animals (Renoux, 
1980). This phenomenon was confirmed with rainbow trout in the late 1980s (Siwicki, 
1989). Levamisole also has been shown with several aquatic species to be a potent 
immunostimulant in modulation of leukocyte cytotoxic activity (Cuesta et al., 2002), 
phagocytosis ((Mulero et al., 1998; Findlay and Munday, 2000), respiratory burst 
(Siwicki, 1989; Mulero et al., 1998), antibody response (Jeney and Anderson, 1993; 
Cuesta et al., 2004) and macrophage-activating factor (Mulero et al. 1998a). Levamisole 
has been reported to be capable of enhancing resistance to pathogenic bacteria such as 
Vibrio anguillarum (Kajita et al., 1990), Aeromonas hydrophila (Baba et al., 1993), 
Paramoeba sp. (Findlay et al., 2000; Munday and Zilberg, 2003), P. fluorescent (Baruah 
and Prasad, 2001) Edwardsiella tarda (Sahoo and Mukherjee, 2002), Photobacterium 
damselae (Leano et al., 2003) and nematodes such as Anguillicola crassus (Geets et al., 
1992). This drug does not have direct effects on bacteria, viruses and fungi (Renoux, 
1980); therefore, it mainly serves as an immunotherapy and the possibility of resistance 
development by pathogenic bacteria is rather minimal. Because levamisole can be 
effectively delivered via dietary supplementation, it would be much more feasible for 
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industry use, compared to injection and immersion. Besides the immunostimulating 
influence and potential use in fish health management, levamisole also was recognized to 
enhance growth of gilthead sea bream (Mulero et al., 1998), carp (Siwicki and Korwin-
Kossakowski, 1988) and several terrestrial animals (Cabaj et al., 1995), although the 
administration protocols including dose and time still have not been fully defined. A 
previous study with hybrid striped bass failed to demonstrate a growth-enhancing effect 
of dietary levamisole, probably because of limited supplemental levels (Li et al. 2004b). 
In addition, some research showed that administration of levamisole via immersion or 
intraperitoneal injection can modulate adaptive immunity and antibody production (Jeney 
and Anderson, 1993; Midtlyng et al., 1996), although efficacy of levamisole as an 
adjuvant on vaccination has been debated (Morrison et al., 2000, 2001). Administration 
of levamisole through dietary supplementation has been reported to enhance antibody 
response to hepatitis B vaccination in humans (Kayatas, 2002); however, research on 
possible effects on antibody production in fish is currently very limited to the best of our 
knowledge. This experiment was designed to explore the effects of dietary levamisole on 
growth performance, innate and adaptive immunity and resistance of hybrid striped bass 
to S. iniae and A. hydrophila infection.    
 
2. Materials and Methods 
2. 1 Experimental Diets 
 The basal diet, which utilized menhaden fish meal as the protein source, was 
formulated to contain 40% protein, 10% lipid and an estimated digestible energy level of 
3.5 kcal/g (Table 17). This diet satisfied and/or exceeded all known nutrient requirements  
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Table 17. Dietary composition and macronutrient profile analysis 
 Levamisole (mg kg-1 diet) 
Constituents 0 100 250 500 1000 
Ingredient (% dry weight) 
Menhanden fish 
meal a 59.2 59.2 59.2 59.2 59.2 
Dextrin b 25.0 25.0 25.0 25.0 25.0 
Menhaden oil a 4.4 4.4 4.4 4.4 4.4 
Mineral premix c 3.0 3.0 3.0 3.0 3.0 
Vitamin premix c 4.0 4.0 4.0 4.0 4.0 
Carboxymethyl 
cellulose b 2.0 2.0 2.0 2.0 2.0 
Cellulose b 2.4 2.39 2.375 2.35 2.3 
Levamisole 0 0.01 0.025 0.05 0.1 
Analyzed proximate composition (% dry matter) d 
Dry matter 91.9 90.0 89.8 91.8 89.7 
Crude protein 
(N×6.25) 
41.2 41.8 41.7 41.2 40.8 
Crude lipid 10.2 10.8 10.7 11.0 10.5 
Ash 16.0 15.9 16.1 14.6 16.1 
a Omega Protein Corporation, Houston, TX. Menhaden fish meal contained 67.6% 
protein and 9.5% lipid on a dry-weight basis. 
b US Biochemical Corp., Cleveland, OH. 
c Same as Li et al. 2004a.  
d Means of two analyses.  
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of hybrid striped bass (Webster, 2002). Levamisole (Sigma, St. Louis, MO, USA) was 
added to the diet at 100, 250, 500, 1000 mg/kg diet in place of equal amounts of cellulose. 
Procedures for diet preparation and storage were as previously described by Webb and 
Gatlin (2003). Experimental diets were analyzed for moisture, crude protein, crude lipid 
and ash following established procedures (Webb and Gatlin, 2003) to confirm formulated 
composition.    
 
2.2 Feeding trial 1 
The first feeding trial was conducted to evaluate incremental levels of dietary 
levamisole on growth performance, non-specific immune responses as well as resistance 
of hybrid striped bass to S. iniae infection. Prior to initiation of this feeding trial, juvenile 
hybrid striped bass obtained from Keo Fish Farm (Keo, AR) were subjected to a 2-week 
conditioning period, to adjust to standardized regimes in a recirculating culture system 
consisting of 110-l aquaria.  Water flow rate was maintained at approximately 650 
ml/min via a recirculating system which maintained adequate water quality (total 
ammonia nitrogen ≤ 0. 6 mg/l) through biological and mechanical filtration. Salinity was 
maintained at 2.5-3.5 ‰ using well water and synthetic sea salt (Fritz Industries Inc., 
Dallas, TX). Low pressure electrical blowers provided aeration via air stones and 
maintained dissolved oxygen (DO) levels at or near saturation. Water temperature was 
controlled by ambient air and remained at 26 ± 1 oC throughout the trial. A 12 h light: 
12h dark photoperiod was maintained with fluorescent lights controlled by timers. 
Groups of 14 hybrid striped bass weighing approximately 40.6 g/fish were stocked into 
individual aquaria such that initial weight averaged 565 ± 12 g/group.  The basal and 
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experimental diets were fed to three replicate groups of fish for 3 weeks.  All groups were 
fed their respective diets at the same fixed rate (initially 3% of body weight per day and 
gradually reduced to 2%), which approached apparent satiation. Growth and feed 
efficiency were monitored weekly by collectively weighing each group of fish. 
 
2.3 Sample collection and innate immune response assays 
At the end of this feeding trial, three representative fish from each aquarium were 
anesthetized with an overdose of MS-222 and blood collected from the caudal 
vasculature. After a sample of whole blood was taken for hematocrit determination, 
serum was isolated by centrifugation (3000 × g for 5 min) and kept at –80 oC. Head 
kidney macrophages were isolated by following the procedure described by Secombes 
(1990) with minor modifications as described by Sealey and Gatlin (2002b). Briefly, head 
kidneys from the three fish per tank were removed, pooled and finely ground with a  
tissue homogenizer. The homogenate was pushed through 100-µm mesh and layered on a 
34%/51% Percoll gradient. After being centrifuged for 30 min at 400 × g at 4 oC, cells 
were collected and washed with Hank’s balanced salt solution twice. The cells were 
counted and viability was determined by trypan blue to be more than 95%.  
Serum lysozyme activity was determined by turbidimetric assay as described by 
Jørgensen et al. (1993). A lysozyme activity unit was defined as the amount of enzyme 
producing a decrease in absorbance of 0.001 min-1 at pH = 6.1. Serum peroxidase was 
analyzed by following the procedure described by Rodriguez et al. (2003). Extracellular 
and intracellular superoxide anion production of head kidney macrophages was 
determined following the procedure of Secombes (1990). The amount of extracellular 
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superoxide anion was calculated from the formula: nanomoles superoxide anion per well 
= (∆ absorbance after 60 min × 100)/6.3 (Pick and Mizel, 1981). 
 
2.4. S. iniae challenge  
After 4 weeks of feeding upon the experimental diets, representative fish were 
exposed to an estimated LD50 dose of Streptococcus iniae. The isolate of S. iniae was 
kindly supplied by the Texas Veterinary Medical Diagnostic Laboratory (TVMDL) and 
confirmed by polymerase chain reaction. This isolate was grown in brain-heart infusion 
broth (EM Science, Darmstadt, Germany) in a shaking bath at 29 oC overnight. The 
concentration of bacterial suspension was determined by the serial plate count method 
and diluted to 2.6 × 106 CFU/ml in fresh well water. Twenty-four fish from each 
treatment (8 fish from each triplicate aquarium), pooled separately in mesh baskets, were 
immersed in the bacterial suspension for 2 hours. After bath exposure, the fish from each 
dietary treatment were divided into three groups of 8, and placed into 38-l flow-through 
aquaria in an isolated culture system. Water temperature was maintained at 27 ± 1 oC 
with immersion heaters. Fish continued to be fed their respective diets to apparent 
satiation twice daily, and mortality was monitored for 3 weeks. The brains of both dead 
fish and surviving fish were streaked on modified selective agar to determine infection 
status and confirm death from S. iniae (Nguyen and Kanai, 1999). Infected fish were 
counted as having suffered mortality.    
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2.5. Feeding trial 2 and A. hydrophila challenge 
 The second feeding trial was conducted to explore the effect of dietary levamisole 
on resistance of hybrid striped bass to A. hydrophila infection. Prior to initiation of this 
feeding trial, juvenile hybrid striped bass obtained from Keo Fish Farm (Keo, AR) were 
subjected to a 2-week conditioning period to adjust to standardized regimes in a 
recirculating culture system consisting of 38-l aquaria. Water quality and environmental 
factors were maintained as described above. Groups of 18 (18.4 ± 0.4 g/fish, mean ± S. 
D.) hybrid striped bass were stocked into individual aquaria. Basal and experimental diets 
with the same graded levels of levamisole as in trial 1 were fed to two replicate groups of 
fish for 3 weeks.  All groups were fed their respective diets at the same fixed rate 
(initially 3% of body weight per day and gradually reduced to 2%), which approached 
apparent satiation. At the end of 3 weeks, A. hydrophila (ATCC 49140) was obtained 
from ATCC (Manassas, VA, USA) and was grown in brain-heart infusion broth (EM 
Science, Darmstadt, Germany) in a shaking bath at 26 oC overnight. The bacteria were 
centrifuged and resuspended in PBS. Because the experimental infection model for A. 
hydrophila had not been established with hybrid striped bass, an estimated LD50 
established with goldfish (Rahman et al., 2001), which has the most similar 
environmental requirements as hybrid striped bass was employed in the present study. 
Fish were anesthetized by MS-222 and 0.2 ml of 1 × 107 CFU/ml bacterial suspension 
was injected intraperitoneally. Fish were delivered to the isolated flow-through system 
consisting of 38-l aquaria and equally distributed as 12 fish in each of three aquaria per 
treatment. . Water temperature was maintained at approximate 25 °C by ambient air. 
Salinity of water was 0.5 ‰. The morbidity and mortality were monitored three times per 
 84
day for 30 days, although no mortality was observed after 20 days post-challenge. Fish 
were fed their originally assigned diets once per day during this period. Moribund fish 
were randomly sent to the TVMDL to confirm death from A. hydrophila infection.  
 
2.6. Feeding trial 3 and assays of specific antibody titer against S. iniae 
The third feeding trial was conducted to determine the effect of dietary 
supplementation of levamisole on serum antibody titer against S. iniae. Groups of 8 
hybrid striped bass weighing approximately 36.6 ± 0.5 g/fish (mean ± S. D.) were 
stocked into individual 38-l aquaria. The basal and levamisole-supplemented diets were 
fed to two replicate groups of fish for 3 weeks. All groups were fed their respective diets 
at the same fixed rate (initially 3% of body weight per day and gradually reduced to 2%) 
which approached apparent satiation. At the end of the 3-wk feeding, ten fish of similar 
size (approximately 56 g/fish) from each treatment were immunized following the 
procedure established by Sealey and Gatlin (2002). Briefly, each fish was injected 
intraperitonealy (IP) with 4 x108 formalin-killed Streptococcus iniae cells/fish. Fish were 
given a booster IP injection of the same dose 10 days post-immunization. Fish continued 
to be fed their respective diets twice daily to apparent satiation. Surviving fish were bled 
7 days after the booster IP injection. Serum was separated following the procedure 
described above and agglutination antibody titers were determined by microtitration 
agglutination as described by Roberson (1990). A positive reaction was described by the 
presence of a button with fuzzy edges; whereas, a negative reaction consisted of a round 
precipitate with clearly defined circular margins (Sealey and Gatlin, 2002). Antibody titer 
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was expressed as the reciprocal log base-2 of the highest dilution demonstrating a 
positive reaction. 
All animal procedures used in this study were approved by the Texas A&M 
University Animal Care and Use Committee.  
2. 7. Statistics 
Data from the feeding trials, immune response assays and the bacterial challenge 
were subjected to analysis of variance and Duncan's multiple-range test using the 
Statistical Analysis System. Differences in treatment means were considered significant 
at P < 0.05. 
 
3. Results 
3.1 Growth performance (feeding trial 1)  
After the 3-week feeding period in feeding trial 1, enhanced weight gain was 
generally observed in fish fed the diets supplemented with low concentrations (<500 
mg/kg) of levamisole (Table 18).  Dietary supplementation of levamisole at 100 mg/kg 
significantly (P<0.05) enhanced growth and feed efficiency by approximately 10%, 
compared to fish fed the basal diet (Table 18).  However, fish fed the diet supplemented 
with 1000 mg levamisole/kg diet showed growth retardation, reduced feed intake and 
feed efficiency. Survival during feeding trial 1 was high and no significant differences 
were observed among treatments (Table 18).  
The growth responses generated from feeding trial 2 and 3 showed a similar trend  
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Table 18. Performance of hybrid striped bass fed diets containing various levels of 
levamisole for 3 weeks in feeding trial 1a 
Levamisole (mg/kg) Growth (% 
increase) 
Feed efficiency (g 
gain/ g feed) 
Survival (%) 
0 50.2 y 0.84 yz 97.6 
100 55.2 x 0.93 x 97.6 
250 53.4 xy 0.90 x 100 
500 52.4 xy 0.87 xy 97.6 
1000 46.6 z 0.78 yz 97.6 
    
P 0.014 0.004 0.903 
Pooled. S. E. 1.412 0.020 2.128 
a Values represent means of five replicate groups. Values in a column that do not have the 
same superscript are significantly different at P≤ 0.05 based on Duncan’s multiple range 
test. 
      b Fish initially weighed 40.6 ± 0.6 (mean ± 0.6) g each. 
      c Significance probability associated with the F statistic.
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as in feeding trial 1, although the growth enhancement was not significant at P<0.05 
based on only duplicate groups of fish. However, growth retardation and depressed feed 
intake and feed efficiency resulting from an overdose of levamisole (1000 mg/kg) were 
confirmed (data not shown).   
 
3.2 Select innate immune response assays (feeding trial 1) 
The average hematocrit of juvenile hybrid striped bass was relative high in the 
present study without significant dietary influences (Table 19). Although the average 
serum peroxidase level of fish fed the levamisole-supplemented diet was noticeably 
higher than fish fed the basal diet, it was not statistically significant  (Table 19).  Serum 
lysozyme of fish fed 1000 mg levamisole/kg diet tended to be lower compared with that 
of fish fed the other diets (Table 19). Fish fed the diet with 250 mg levamisole/kg had 
significantly (P<0.05) higher intracellular superoxide anion production than fish fed 
other diets; however, the extracellular superoxide anion production was not significantly 
influenced by dietary supplements (Table 19).      
 
3.3 S. iniae challenge (feeding trial 1) 
The disease challenge with live S. iniae resulted in approximately 50% mortality 
of fish fed the basal diet after 19 days. The relative percent survival (RPS) for fish fed 
100, 250, 500 and 1000 mg levamisole/kg diet were 43.7, 50.0, 62.5 and -25, respectively. 
The moribund fish showed typical signs of S. iniae infection including extremely erratic 
swimming, cloudiness of the eyes, haemorrhages around mouth and base of fins, dark 
pigmentation and slow acceptance or refusal of feed. Because of the large variance,  
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which possibly resulted from subsequent infection from cohabitation instead of 
immersion, the influence of dietary levamisole on survival of hybrid striped bass after 
challenge with S. iniae cannot be demonstrated in this study (Fig. 4a).  
 
3.4 A. hydrophila challenge (feeding trial 2) 
The IP injection resulted in cumulative mortality of approximately 40% over the 
20 days post-challenge (Fig. 2). Mortality was monitored for 30 days and no mortality 
was observed after 20 days. The bacteria caused a rapid infection and mortality began 48 
hours after exposure. Infected fish did not show noticeable signs of septicemia, although 
all the challenged fish showed sluggish movement and slow acceptance or refusal of diet, 
as well as reddening of the skin. The relative percent survival (RPS) for fish fed 100, 250, 
500 and 1000 mg levamisole/kg diet were 21.6, 18.7, 33.8 and -2.3, respectively. 
Possibly because of the infection from cohabitation in individual aquarium, the variation 
in mortality among replicate tanks was high. Fish fed the levamisole-supplemented diet 
for 3 weeks (less than 500 mg/kg provide exact level) failed to show significantly 
improved survival than fish fed the basal diet.  
 
3.5 Agglutinating antibody titers against S. iniae (feeding trial 3) 
After booster injection with formalin-killed S. iniae, agglutinating antibody was 
detected in most of the fish (approximately 82%). The variation among individual fish 
across dietary treatment was large and no significant differences were observed (Fig. 4c).  
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4. Discussion 
Fish growth and disease resistance are two primary concerns in aquaculture. A 
wide variety of antibiotics and other antibacterial agents, antiparasitic drugs, ionophores  
as well as anabolic and xenobiotic agents have been screened for growth control of 
terrestrial animals (reviewed by Beermann, 1989); however, current knowledge in this 
area with respect to aquatic animals is very limited. Because the growth rate of fish is 
generally slower than farmed terrestrial animals, growth regulation by dietary 
manipulation should be a prioritized topic in aquaculture research. Levamisole is one of 
the most recognized immunostimulants for aquaculture (reviewed by Sakai, 1999).  It has 
been shown to enhance growth of carp (Siwicki and Korwin-Kossakowski, 1988) and 
gilthead sea bream (Mulero et al., 1998), by immersion and short-term (10 days) oral 
administration, respectively. To the best of our knowledge, a detailed feeding protocol to 
induce rapid fish growth by levamisole has not been reported. In the present study, 
juvenile hybrid striped bass fed low doses of levamisole (100-250 mg/kg) had 
significantly enhanced feed efficiency, and growth increased by approximately 10% after 
3 weeks of feeding. This confirmed the growth-promoting effects of levamisole reported 
by other researchers and also may represent a new strategy to enhance industrial 
production. Based on mammalian research, levamisole can be extensively and rapidly 
metabolized by the liver such that residues are very low (Kayatas, 2002). This 
characteristic would be very suitable for use in hybrid striped bass culture in addition to 
the low cost and low effective dosage of this compound. The present study also 
confirmed the previous observation that excessive use of levamisole (1000 mg/kg) 
resulted in growth depression and reduction of feed efficiency (Li et al., 2004b), although 
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the possible influence of levamisole overdose on immunity and disease resistance was not 
demonstrated. Regardless the significant benefits conferred by feeding levamisole-
supplemented diets for 3-weeks, information pertaining to long- term administration and 
potential tissue accumulation of levamisole is still needed to guarantee its safe and 
optimal use. In addition, the mechanism by which levamisole regulates growth and 
possibly influences the hypothalamus–pituitary gland –liver axis is important to 
characterize for potentially maximizing the benefit of levamisole; therefore, this warrants 
further study.   
 It has been shown that levamisole is capable of enhancing immune responses 
and/or reducing losses from bacteria and/or parasitic infections in many cultured species 
including carp (Siwicki, 1989; Baba et al., 1993), gilthead sea bream (Mulero et al., 
1998), rainbow trout (Siwicki et al., 1989; Kajita et al., 1990; Jeney and Anderson, 1993), 
Atlantic salmon (Findlay and Munday 2000; Findlay et al., 2000; Morrison et al., 2001) 
rohu (Sahoo and Mukherjee, 2002), eel (Geets et al., 1992), cobia (Leano et al., 2003) 
and giant prawn (Baruah and Prasad, 2001). In the present study, only intracellular 
superoxide anion production of head kidney cells of fish fed the diet supplemented with 
250 mg levamisole/kg was significantly higher than that of fish fed the other 
experimental diets. Because respiratory burst of phagocytic cells is recognized as an 
important defensive mechanism of fish and other animals, this enhancement may result in 
resistance to certain pathogens. Because both S. iniae and A. hydrophila are not 
intracellular pathogens, challenge with other pathogens such as viruses and intracellular 
bacterial species may be important to fully define the potential use of dietary levamisole 
to enhance fish health management. Based on the results from controlled challenges with 
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S. iniae and A. hydrophila after 3 weeks of feeding levamisole-supplemented diets, the 
influence on resistance to infection of these two bacterial species was marginal. Because 
dose and timing are important factors influencing the efficacy of immunostimulants 
(Sakai, 1999), other administration protocols should be investigated thoroughly before a 
definite conclusion can be drawn concerning the effectiveness of levamisole in protecting 
against S. iniae and A. hydrophila infection. In addition, although dietary effects on 
hematocrit are not significant, the hematocrit of all treatments in the present study were 
higher than any published data on hybrid striped bass (Sealey and Gatlin, 2002a; Li and 
Gatlin, 2003; Li et al., 2004a). Because high hematocrit (over 50%) is sometimes 
considered as an indicator of stress (Barton, 2000), this phenomenon may complicate the 
interpretation of lack of dietary difference in resistance to the two bacteria species, even 
though no obvious stressor can be traced in the present study. The serum peroxidase and 
lysozyme levels were within a range that have been reported (Sealey and Gatlin, 2002; Li 
and Gatlin, 2003; 2005; Jaramillo and Gatlin, 2004) and were not affected by dietary 
supplementation of levamisole. Because levamisole has been hypothesized to influence 
immunity by changing cytokine production such as interferon, interleukin 1 and 2 
(Redondo et al., 1987; Kimball et al., 1991), measurement of responsive cytokine 
production may provide insight to optimal use of levamisole in aquafeeds.  
Administration of levamisole by immersion and injection has been reported to be 
capable of enhancing specific antibody production in rainbow trout (Jeney and Anderson, 
1993), Atlantic salmon (Midtlyng et al., 1996) and rohu (Sahoo et al., 1999), respectively. 
Sahoo and Mukherjee (2002) also reported dietary levamisole (5 mg levamisole/kg/day 
for every 3 days) restored specific immunity of rohu depressed by Aflatoxin B1, but did 
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not influence healthy fish. The agglutinating antibody titer of juvenile hybrid striped bass 
against S. iniae failed to show significant or noticeable dietary effects in the present study, 
which is consistent with the observations made by Sahoo and Mukherjee (2002). The 
variance among individual fish fed the same diets in the present experiment was rather 
high, which lessens the conclusiveness of this result. Because possible influences of 
genetic polymorphisms on fish antibody responses are not fully defined, the genetic 
background of fish for experiments usually has not been strictly controlled. In addition to 
possible genetic variation, a recent study showed that antiserum should be stored in -4°C 
instead of -73°C to maintain biological activity (Nitzan et al., 2003) and suggested a 
significant modification of traditional protocol. These uncertainties need to be clarified to 
provide a definitive answer pertaining to the potential use of dietary levamisole as an 
adjuvant for vaccination against S. iniae. 
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CHAPTER VII 
 
EXCESSIVE DIETARY LEVAMISOLE SUPPRESSES GROWTH 
PERFORMANCE OF HYBRID STRIPED BASS (Morone chrysops×M. saxatilis), 
AND ELEVATED LEVAMISOLE IN VITRO IMPAIRS MACROPHAGE 
FUNCTION* 
 
1. Introduction 
Traditionally, antibiotics have been the most important chemotherapeutics in 
aquaculture for prevention and treatment of bacterial diseases. However, the use of 
antibiotics in aquaculture may pose threats such as development of bacterial strains that 
are more resistant to antibiotic treatment, or the occurrence of antibiotic residues in 
farmed fish for human consumers (FAO, 2002). Based on these two considerations, the 
potential uses of existing antibiotics and approval of new ones for aquaculture have been 
very limited. Alternatively, immunostimulants hold promise as alternative strategies 
against infectious aquatic diseases and have received heightened attention in recent years 
(Gatlin, 2002). One such compound, levamisole, an antihelminthic drug commonly used 
with terrestrial livestock, has been shown with several aquatic species to be a potent 
immunostimulant in modulation of T-cell function (Renoux, 1980), cytotoxic activity of 
leukocytes (Cuesta et al, 2002a), phagocytosis (Mulero et al., 1998a), respiratory burst  
 
 
* Reprinted from Aquaculture Research, Vol 35, Li, P., Wang, X., Gatlin, D. M. III, Excessive 
dietary levamisole suppresses growth performance of hybrid striped bass (Morone 
chrysops×M. saxatilis), and elevated levamisole in vitro impairs macrophage function, pp. 
1380-1383, Copyright 2004, with permission from Blackwell Publishing.   
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(Mulero et al., 1998a; Li and Gatlin unpublished data) and macrophage-activating factor 
(Mulero et al., 1998a). It also has been reported to enhance resistance to amoebic gill  
disease of Atlantic salmon (Findlay et al, 2000; Munday and Zilberg, 2003) and 
swimbladder nematode infection of eel (Geets et al., 1992) as well as improve growth 
performance when administered orally (Mulero et al., 1998a) or by water bath (Siwicki  
and Korwin-Kossakowski, 1988). Thus, levamisole has shown potential as a dietary 
supplement for some fish species including hybrid striped bass, an important 
aquacultured fish in the United States. However, based on studies with terrestrial animals, 
levamisole can cause acute and chronic toxicity when dose and administration time are 
not proper (JECFA, 1991). Toxicity of levamisole to Atlantic salmon during sea water 
bath exposure was recently described (Munday and Zilberg, 2003). However, the toxic 
level of dietary levamisole in fish is not fully defined. Therefore, the present study was 
conducted to determine effects of dietary levamisole on growth performance of hybrid 
striped bass and in vitro macrophage response to different levels of levamisole.  
 
2. Materials and Methods 
2.1. In-vivo feeding trial 
The basal diet was composed of 59.2% menhaden fish meal (Special Select®, 
Omega Protein Corporation, Reedville, VA, USA), 4.4% menhaden fish oil (Omega 
Protein Corporation, Reedville, VA, USA), 25% dextrin, 2% carboxymethyl cellulose, 
2.4% cellulose (US Biochemical Corp., Cleveland, OH, USA), 3% vitamin premix and 
4% mineral premix. This diet was formulated to contain 40% protein, 10% lipid and an 
estimated digestible energy level of 3.5 kcal/g. The vitamin and mineral premix 
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formulation was described by Li et al. (2004). This diet satisfied and/or exceeded all 
known nutrient requirements of hybrid striped bass (Webster, 2002) or other warmwater 
fishes (NRC, 1993). Levamisole (Sigma, St. Louis, MO, USA) was added to the basal 
diet in place of equal amounts of cellulose to provide either 500 or 1000 mg/kg diet. 
Prior to initiation of this feeding trial, juvenile hybrid striped bass obtained from 
Keo Fish Farms (Keo, AR) were subjected to a 2-week conditioning period to adjust to 
standardized regimes in a recirculating culture system consisting of 110-l aquaria.  
Groups of 20 hybrid striped bass weighing approximately 6.5 g/fish were stocked into 
individual aquaria such that initial weight averaged 130.4 ± 1.6 g/group (mean ± s. e.).  
Salinity was maintained at 2.0 ± 0.5 ppt. The basal and experimental diets were all fed to 
three replicate groups of fish for 4 weeks.  All groups were fed their respective diets 
twice daily at the same fixed rate (Table 20) to maintain a level approaching apparent 
satiation. Growth and feed efficiency were monitored weekly by collectively weighing 
each group of fish. 
 
2.2. In-vitro study 
 Twenty hybrid striped bass maintained on a commercial diet (Rangen, Inc., 
Angleton, TX, USA) in earthen ponds were captured and subjected to conditioning (25 ± 
1 oC, 2.5 ppt salinity) in a 1100-l recirculating tank for 1 week before isolating head 
kidney cells. Twenty fish were killed by pithing and head kidneys were removed and 
pooled. The macrophages were prepared following the procedure described by Secombes 
(1990) with minor modifications as described by Sealey and Gatlin (2002). Cell viability 
was determined to be greater than 95% by trypan blue (0.4%) exclusion. A100-µl aliquot 
 98
of cell suspension with 2 × 106 cells was added to each well of three, 96-well plates. 
Various levels (0, 1, 10, 100, 1000 µg ml-1) of levamisole were added to L-15 media 
(Cellgro®, Herndon, VA, USA) with 0.1 % fetal calf serum (Hyclone®, Logan, UT, USA), 
100 unit ml-1 penicillin and 0.1 mg ml-1 streptomycin (Sigma, St. Louis, MO, USA). Each 
levamisole dose was added to four replicate wells in each of the three 96-well plates. 
Plates were incubated for 24, 48 and 72 h at room temperature. Media were changed 
every 24 h in plates incubated for 48 and 72 h. Intracellular superoxide anion production 
was determined by the procedure of Secombes (1990). All data were subjected to analysis 
of variance and Duncan's multiple-range test using the Statistical Analysis System (SAS, 
1985).  Differences in treatment means were considered significant at P < 0.05. 
 
3. Results and Discussion 
The growth trial showed significantly suppressed growth and feed efficiency of 
juvenile hybrid striped bass after 3 weeks of consuming the diet with 1000 mg 
levamisole/kg (approximately 51.6 mg/kg body weight daily), while this trend became 
noticeable after 2 weeks of feeding (Table 20). Although side-effects of levamisole-
adjuvanted vaccine including mild pathology of gills (Morrison, Nowak & Carson 2001) 
and suppressed antibody titer (Morrison, Nowak & Carson 2000) have been reported, the 
chronic toxicity of dietary levamisole to hybrid striped bass observed in this present study 
is the first report in aquaculture to the best of our knowledge. JECFA (1991) reported in a 
30-day feeding trial 50 mg levamisole/kg body weight daily resulted in moderate 
reduction in weight gain of rats. This chronic toxicity level of dietary levamisole is very 
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similar to that observed in the present study. This study failed to show beneficial effects 
of levamisole on growth based on the 4-week trial duration. This result is not conclusive 
due to limited supplementation levels and administration time; therefore, additional 
research is warranted. One very recent study (Leano et al., 2003) showed 2-week feeding 
with 1000 mg levamisole/kg diet enhanced non-specific immunity and disease resistance 
of cobia (Rachycentron canadum) fingerlings without any noticeable effects on growth. 
This may indicate a species-specific difference in levamisole tolerance.    
The in-vitro study showed 1000 µg levamisole/ml noticeably and significantly 
(P<0.0001) suppressed superoxide anion production after 24-h incubation (Fig. 5), 
possibly attributable to reduced cell viability or availability of intracellular NADPH 
oxidase (Fig. 5). Even 100 µg levamisole/ml suppressed macrophage function after 48-h 
incubation. The suppressive effect of levamisole on head kidney cells was confirmed to 
be dose- and time- dependent. Siwicki and Cossarini- Dunier (1990) reported the 
suppressive effects of levamisole (100-200 µg/ml) on phagocytosis of carp spleen and 
head kidney macrophages. The in-vitro toxicity level of levamisole to hybrid striped bass 
kidney leukocytes in the present study is similar with those reported in the carp study. 
Mulero et al. (1998b) reported that greater than 10 µg levamisole/ml could kill seabream 
leucocytes. Results from the present study showed that kidney cells of hybrid striped bass 
could tolerate this level without an obvious decrease in cell viability.  Siwicki et al. (1990) 
reported enhanced respiratory burst of carp intact spleen after incubation with 5 µg 
levamisole/ml. In a related study (Siwicki and Cossarini- Dunier, 1990), carp macrophage 
function was enhanced when incubated with 0.8 – 6.2 µg levamisole/ml. However, the 
present study and that of Mulero et al. (1998b) failed to show the benefical influences 
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of levamisole on respiratory burst of head kidney cells of hybrid striped bass or githead 
sea bream. Mulero et al. (1998b) hypothesized enhanced production of macrophage 
activating factors by stimulation with levamisole influenced macrophage responses. 
Additional research is warranted to determine the effects of levamisole on growth and 
immunity of hybrid striped bass by optimizing levamisole dosage and timing of 
administration. 
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CHAPTER VIII 
 
CONCLUSIONS 
 
Six studies were conducted with hybrid striped bass to evaluate various dietary 
supplements including autolyzed brewers yeast, the commercial prebiotic GroBiotic®-A, 
oligonucleotides and levamisole in terms of their effects on growth, immunological 
responses and disease resistance.  
In the first study with brewers yeast, enhanced weight gain and feed efficiency 
were generally observed in fish fed the diets supplemented with yeast at 2% compared to 
the basal diet in both trials. In the second trial, body composition of whole fish, hemocrit 
and serum lysozyme levels were observed to be within normal ranges and not influenced 
by yeast supplementation. After 9 weeks of feeding in the second trial, exposure to S. 
iniae resulted in no mortality and reduced signs of disease in fish fed diets supplemented 
with 2% and 4% brewers yeast, while 20% mortality was observed in fish fed the control 
diet (P=0.1). Blood neutrophil oxidative radical production, extracellular and intracellular 
superoxide anion production of head kidney macrophages and serum lysozyme were 
measured after 16 weeks of feeding each diet, in the second trial. Fish fed the diet with 
2% brewers yeast had significantly (P<0.01) higher blood neutrophil oxidative radical 
and extracellular superoxide anion production of head kidney macrophages than control 
fish. Based on the results of the first study, it was concluded that brewers yeast positively 
influenced growth performance and feed efficiency of hybrid striped bass as well as 
resistance to S. iniae infection. In addition, results of immune response assays 
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demonstrated that brewers yeast can be administered for relatively long periods without 
causing immunosuppression.  
The second study compared the effects of dietary supplementation of a 
commercial prebiotic GroBiotic®-A and brewers yeast on the performance of juvenile 
hybrid striped bass. Enhanced growth performance was generally observed in junveile 
fish fed the diets supplemented with GroBiotic®-A or brewers yeast compared to the 
basal diet after 7 weeks of feeding in trial 1. Significantly higher (P<0.05) feed efficiency 
was observed in fish fed diets supplemented with 1% and 2% GroBiotic®-A. After 4 
weeks of feeding in trial 2, growth and feed efficiency were not significantly affected by 
the various dietary treatments, although some immunological responses were altered. 
Neutrophil oxidative radical anion production and intracellular superoxide anion 
production of head kidney macrophages tended to be higher in fish fed diets 
supplemented with brewers yeast or GroBiotic®-A, while extracellular superoxide anion 
production of head kidney macrophages from fish fed diets with 1% and 2% brewers 
yeast and 1% GroBiotic®-A was significantly (P<0.01) higher than that of fish fed the 
basal diet. All groups of fish fed brewers yeast and GroBiotic®-A showed significantly 
(P<0.01) enhanced survival (73.3–90%) after bath exposure to Streptococcus iniae 
compared with fish fed the basal diet (53.3%). These data substantiated that GroBiotic®-
A and a partially autolyzed brewers yeast can serve as functional feedstuffs in the diet of 
hybrid striped bass by enhancing growth performance and immunological responses. 
The third study was to evaluate the dietary supplementation of GroBiotic®-A and 
brewers yeast in the diet of sub-adult hybrid striped bass. It confirmed previous 
observations of positive effects of these supplements on growth of juvenile hybrid striped 
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bass. At the end of 16 and 21 weeks of the feeding trial, fish fed 2% brewers yeast had 
significantly higher feed efficiency than those fed the other diets. An in situ 
mycobacterial challenge employed in this experiment resulted in overall cumulative 
mortality of approximately 25%. Fish fed 2% GroBiotic®-A had significantly (P < 0.05) 
enhanced survival (80%) compared with those fed the other treatments (72–73%) at the 
end of 21 weeks. It is concluded that dietary supplementation of 2% GroBiotic®-A 
showed moderate but significant protection against mycobacterial infection. Dietary 
supplementation of partially autolyzed brewers yeast also may enhance growth 
performance under chronic infection of mycobacteria. Future studies should include 
targeting the dynamics of intestinal microbiology in response to prebiotics, screening for 
beneficial probiotics and developing novel prebiotics and symbiotics (a probiotic together 
with a prebiotic) for health management of hybrid striped bass and other fish species. 
The fourth study failed to show significant differences in growth performance 
between hybrid striped bass fed basal and oligonucleotide-supplemented diets. Body 
composition of whole fish, hematocrit and serum lysozyme levels were observed to be 
within normal ranges and not influenced by dietary nucleotides. However, neutrophil 
oxidative radical production of fish fed the nucleotide-supplemented diet was 
significantly (P=0.011) higher than in fish fed the basal diet. Significantly (P<0.05) 
enhanced survival after exposure to S. iniae also was generally observed in fish fed the 
nucleotide-supplemented diet. In addition, fish fed the nucleotide-supplemented diet 
tended to have a higher antibody response based on microtitration agglutination; 
however, the difference was not statistically significant because of high variation among 
individual fish. Long-term (16 weeks) administration of oligonucleotides in trial 3 of this 
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study failed to show enhancement of immune responses between treatments. It is 
concluded that dietary oligonucleotides positively influenced immune responses and 
resistance of juvenile hybrid striped bass to S. iniae infection.  
The fifth study showed dietary supplementation of levamisole at 100 mg/kg diet 
significantly (P<0.05) enhanced growth and feed efficiency of hybrid striped bass, 
compared with fish fed the basal diet. However, fish fed a diet supplemented with 1000 
mg levamisole/kg diet showed chronic toxicity signs such as inferior growth, reduced 
feed intake and depressed feed efficiency. Although the extracellular superoxide anion 
production of head kidney cells, hematocrit, serum lysozyme and peroxidase were not 
significantly affected by dietary treatments, intracellular superoxide anion production of 
head kidney macrophages of fish fed 250 mg levamisole/kg diet was significantly 
(P<0.05) higher than that of fish fed the other four diets. The hypothesized benefits of 
dietary levamisole supplementation in reducing mortality from infection of pathogenic 
bacteria including S. iniae and A. hydrophila were not observed in two separate 3-week 
feeding trials and disease challenges in the present study. Agglutinating antibody titers of 
individual fish were highly variable and not significantly influenced by dietary 
levamisole at the tested levels. 
The sixth study confirmed the growth-suppressing effect of excessive use of 
levamisole in the diet of hybrid striped bass. An in-vitro trial with hybrid striped bass 
macrophages failed to demonstrate a direct influence of levamisole on superoxide anion 
production; however, elevated levamisole level in the medium significantly suppressed 
the respiratory burst and cell viability. These observations suggested proper 
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administration of immunostimulants such as levamisole is essential for beneficial 
influences and additional studies with this compound are needed.  
Although the concept of functional feeds is novel to the aquaculture industry, it 
represents an emerging new paradigm to develop diets that extend beyond satisfying 
basic nutritional requirements of the cultured organism. Observations with hybrid striped 
bass have shown that research in this area is worthy of further pursuit and may positively 
impact aquacultural production. Further work pertaining to understanding the 
mechanism(s) associated with the dynamics of hormones and cytokines as well as 
expression of immune genes responsible for these beneficial dietary influences should be 
pursued.  
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